<SEC-DOCUMENT>0000950103-25-013257.txt : 20251016
<SEC-HEADER>0000950103-25-013257.hdr.sgml : 20251016
<ACCEPTANCE-DATETIME>20251016144730
ACCESSION NUMBER:		0000950103-25-013257
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20251016
DATE AS OF CHANGE:		20251016

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251397385

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251397386

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp235946_424b2-us2519682d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Pricing Supplement No. 2025-USNCH28875 to Product Supplement No. EA-04-10
dated March 7, 2023,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Underlying Supplement No. 11 dated March 7, 2023, Prospectus Supplement
and Prospectus each dated March 7, 2023</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Filed Pursuant to Rule 424(b)(2)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Registration Statement Nos. 333-270327 and 333-270327-01</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Dated October 15, 2025</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Citigroup Global Markets Holdings Inc. $42,600,000 Trigger Callable
Contingent Yield Notes (with daily coupon observation)</B></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Linked to the Least Performing of the S&amp;P 500<SUP>&reg;</SUP>
Index, the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index Due January 18, 2029</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>All payments due on the notes are fully and unconditionally guaranteed
by Citigroup Inc.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Investment Description</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Trigger Callable Contingent Yield Notes (the &ldquo;<B>notes</B>&rdquo;)
are unsecured, unsubordinated debt obligations of Citigroup Global Markets Holdings Inc. (the &ldquo;<B>issuer</B>&rdquo;), guaranteed
by Citigroup Inc. (the &ldquo;<B>guarantor</B>&rdquo;), linked to the <B>least performing</B> of the S&amp;P 500<SUP>&reg;</SUP> Index,
the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index (each, an &ldquo;<B>underlying</B>&rdquo;).&nbsp;&nbsp;The
notes will pay a contingent coupon on each quarterly coupon payment date if, <B>and only if</B>, the closing levels of <B>all</B> the
underlyings on each trading day during the applicable quarterly observation period are greater than or equal to their respective coupon
barriers.&nbsp;&nbsp;If the closing level of <B>any</B> underlying on <B>any</B> trading day during an observation period is less than
its coupon barrier, no contingent coupon will be paid on the related coupon payment date.&nbsp;&nbsp;On any coupon payment date prior
to the maturity date, the issuer may, in its sole discretion, call the notes in whole, but not in part, and pay you the stated principal
amount per note plus any contingent coupon otherwise due on such coupon payment date and no further amounts will be owed to you.&nbsp;&nbsp;If
the notes have not previously been called by the issuer prior to maturity and the final underlying level of the least performing underlying
is greater than or equal to its downside threshold, you will receive the stated principal amount of your notes at maturity plus any contingent
coupon payment otherwise due on the maturity date.&nbsp;&nbsp;However, if the notes have not been called prior to maturity and the final
underlying level of the least performing underlying is less than its downside threshold, you will receive less than the stated principal
amount of your notes at maturity, resulting in a loss that is proportionate to the decline in the closing level of the least performing
underlying from the strike date to the final valuation date, up to a 100% loss of your investment.&nbsp;&nbsp;The &ldquo;<B>final underlying
level</B>&rdquo; for each underlying is the closing level of such underlying on the final valuation date and the &ldquo;<B>least performing
underlying</B>&rdquo; is the underlying with the lowest underlying return as measured from the strike date to the final valuation date.&nbsp;&nbsp;<B>Investing
in the notes involves significant risks.&nbsp;&nbsp;You may lose a substantial portion or all of your initial investment if the notes
are not called by the issuer in its sole discretion on any coupon payment date prior to the maturity date and the final underlying level
of the least performing underlying is less than its downside threshold.&nbsp;&nbsp;The payment at maturity on the notes is based <U>solely</U>
on the performance of the least performing underlying.&nbsp;&nbsp;You will not benefit in any way from the performance of the better performing
underlyings.&nbsp;&nbsp;You will therefore be adversely affected if <U>any</U> underlying performs poorly, regardless of the performance
of the other underlyings.&nbsp;&nbsp;You will not receive dividends or other distributions paid on any stocks included in the underlyings
or participate in any appreciation of any underlying.&nbsp;&nbsp;The contingent repayment of the stated principal amount applies only
if you hold the notes to maturity or earlier call by the issuer.&nbsp;&nbsp;Any payment on the notes, including any repayment of the stated
principal amount, is subject to the creditworthiness of the issuer and the guarantor and is not, either directly or indirectly, an obligation
of any third party. If the issuer and the guarantor were to default on their payment obligations, you may not receive any amounts owed
to you under the notes and you could lose your entire investment.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 99%; background-color: #788D41; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Features</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR>
    <TD ROWSPAN="7" STYLE="vertical-align: top">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.6pt; text-indent: -12.6pt"><FONT STYLE="font-family: Wingdings">q</FONT><B>&nbsp;Contingent
    Coupon</B> &mdash; We will pay you a contingent coupon on each quarterly coupon payment date if, <B>and only if,</B> the closing levels
    of <B>all</B> the underlyings on each trading day during the applicable quarterly observation period are greater than or equal to their
    respective coupon barriers.&nbsp;&nbsp;Otherwise, no contingent coupon will be paid on that quarterly coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.6pt; text-indent: -12.6pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.6pt; text-indent: -12.6pt"><FONT STYLE="font-family: Wingdings">q</FONT><B>&nbsp;Issuer
Callable </B>&mdash; On any coupon payment date prior to the maturity date, the issuer may, in its sole discretion, call the notes in
whole, but not in part, and pay you the stated principal amount per note plus any contingent coupon otherwise due on such coupon payment
date.&nbsp;&nbsp;If the notes are not called, investors may have full downside market exposure to the least performing underlying at
maturity.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.6pt; text-indent: -12.6pt"><FONT STYLE="font-family: Wingdings">q</FONT><B>&nbsp;Downside
Exposure with Contingent Repayment of Principal at Maturity </B>&mdash; If the notes have not previously been called by the issuer prior
to maturity and the final underlying level of the least performing underlying is greater than or equal to its downside threshold, you
will receive the stated principal amount of your notes at maturity plus any contingent coupon payment otherwise due on the maturity date.&nbsp;&nbsp;However,
if the notes have not been called prior to maturity and the final underlying level of the least performing underlying is less than its
downside threshold, you will receive less than the stated principal amount of your notes at maturity, resulting in a loss that is proportionate
to the decline in the closing level of the least performing underlying from the strike date to the final valuation date, up to a 100%
loss of your investment.&nbsp;&nbsp;<B>Any payment on the notes is subject to the creditworthiness of the issuer and guarantor. If the
issuer and the guarantor were to default on their obligations, you might not receive any amounts owed to you under the notes and you
could lose your entire investment.</B></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<DIV STYLE="float: right; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Key Dates</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; font-size: 12pt"><FONT STYLE="font-size: 10pt">Strike date</FONT></TD>
    <TD STYLE="width: 54%; font-size: 12pt"><FONT STYLE="font-size: 10pt">October 13, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Trade date</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">October 15, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Settlement date</FONT></TD>
    <TD STYLE="padding-left: 13.7pt; font-size: 12pt; text-indent: -13.7pt"><FONT STYLE="font-size: 10pt">October 17, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Observation period end dates</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Quarterly, beginning on January 15, 2026</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 13.7pt; text-indent: -13.7pt">(See page PS-6)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 13.7pt; text-indent: -13.7pt"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Final valuation date<SUP>1</SUP></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">January 16, 2029</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">Maturity date</FONT></TD>
    <TD STYLE="padding-left: 13.7pt; font-size: 12pt; text-indent: -13.7pt"><FONT STYLE="font-size: 10pt">January 18, 2029</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 13.7pt; text-indent: -13.7pt"><SUP>1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</SUP>See
page PS-4 for additional details.</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>NOTICE TO INVESTORS: <FONT STYLE="text-transform: uppercase">The
notes are significantly riskier than conventional debt INSTRUMENTS. THE ISSUER IS NOT NECESSARILY OBLIGATED TO REPAY THE STATED PRINCIPAL
AMOUNT OF THE NOTES AT MATURITY, AND the notes CAN have downside MARKET risk SIMILAR TO the LEAST PERFORMING UNDERLYING.&nbsp;&nbsp;This
MARKET risk is in addition to the CREDIT risk INHERENT IN PURCHASING A DEBT OBLIGATION OF CITIGROUP GLOBAL MARKETS HOLDINGS INC. THAT
IS GUARANTEED BY CITIGROUP INC.&nbsp;&nbsp;You should not PURCHASE the notes if you do not understand or are not comfortable with the
significant risks INVOLVED in INVESTING IN the notes.</FONT></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>YOU SHOULD CAREFULLY CONSIDER THE RISKS DESCRIBED UNDER &lsquo;&lsquo;SUMMARY
RISK FACTORS&rsquo;&rsquo; BEGINNING ON PAGE PS-7 OF THIS PRICING SUPPLEMENT AND UNDER &lsquo;&lsquo;RISK FACTORS RELATING TO THE SECURITIES&rsquo;&rsquo;
BEGINNING ON PAGE EA-7 OF THE ACCOMPANYING PRODUCT SUPPLEMENT IN CONNECTION WITH YOUR PURCHASE OF THE NOTES. EVENTS RELATING TO ANY OF
THOSE RISKS, OR OTHER RISKS AND UNCERTAINTIES, COULD ADVERSELY AFFECT THE MARKET VALUE OF, AND THE RETURN ON, YOUR NOTES. YOU MAY LOSE
SOME OR ALL OF YOUR INITIAL INVESTMENT IN THE NOTES.&nbsp;&nbsp;THE NOTES WILL NOT BE LISTED ON ANY SECURITIES EXCHANGE AND MAY HAVE LIMITED
OR NO LIQUIDITY.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Notes Offering</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We are offering Trigger Callable Contingent Yield Notes Linked to the
Least Performing of the S&amp;P 500<SUP>&reg;</SUP> Index, the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index.&nbsp;&nbsp;The
notes are our unsecured, unsubordinated debt obligations, guaranteed by Citigroup Inc., and are offered for a minimum investment of 100
notes at the issue price described below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 15%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underlyings</B></FONT></TD>
    <TD STYLE="width: 16%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Rate</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 15%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Initial Underlying Levels</B></FONT></TD>
    <TD STYLE="width: 23%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Coupon Barriers</B></FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Downside Thresholds</B></FONT></TD>
    <TD STYLE="width: 11%; text-align: center"><FONT STYLE="font-size: 10pt"><B>CUSIP/ISIN</B></FONT></TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">S&amp;P 500<SUP>&reg;</SUP> Index</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(Ticker: SPX)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD ROWSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">11.20% per annum</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">6,654.72</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">4,658.30, which is 70% of the applicable initial underlying level</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">3,992.83, which is 60% of the applicable initial underlying level</FONT></TD>
    <TD ROWSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">17333P239 / US17333P2395</FONT></TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Nasdaq-100 Index<SUP>&reg;</SUP></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(Ticker: NDX)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">24,750.25</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">17,325.18, which is 70% of the applicable initial underlying level</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">14,850.15, which is 60% of the applicable initial underlying level</FONT></TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Russell 2000<SUP>&reg;</SUP> Index</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(Ticker: RTY)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">2,461.415</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">1,722.991, which is 70% of the applicable initial underlying level</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">1,476.849, which is 60% of the applicable initial underlying level</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>See &ldquo;Additional Terms Specific to the Notes&rdquo; in this
pricing supplement.&nbsp;&nbsp;The notes will have the terms specified in the accompanying product supplement, prospectus supplement and
prospectus, as supplemented by this pricing supplement. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Neither the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;)
nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing
supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus. Any representation to
the contrary is a criminal offense. The notes are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance
Corporation or any other governmental agency.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 24%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 28%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Issue Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 23%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underwriting Discount<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 25%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proceeds<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT>to<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT>Issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Per note</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$10.00</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$0.10</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$9.90</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Total</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$42,600,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$426,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$42,174,000.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">(1) On the date of this pricing supplement, the estimated
value of the notes is $9.837 per note, which is less than the issue price.&nbsp;&nbsp;The estimated value of the notes is based on proprietary
pricing models of Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;) and our internal funding rate.&nbsp;&nbsp;It is not an indication
of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any, at which CGMI or any other person may
be willing to buy the notes from you at any time after issuance. See &ldquo;Valuation of the Notes&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">(2) The underwriting discount is $0.10 per note. CGMI,
acting as principal, has agreed to purchase from Citigroup Global Markets Holdings Inc., and Citigroup Global Markets Holdings Inc. has
agreed to sell to CGMI, the aggregate stated principal amount of the notes set forth above for $9.90 per note. UBS Financial Services
Inc. (&ldquo;<B>UBS</B>&rdquo;), acting as agent for sales of the notes, has agreed to purchase from CGMI, and CGMI has agreed to sell
to UBS, all of the notes for $9.90 per note. UBS will receive an underwriting discount of $0.10 for each note it sells in this offering.&nbsp;&nbsp;UBS
proposes to offer the notes to the public at a price of $10.00 per note.&nbsp;&nbsp;For additional information on the distribution of
the notes, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement.&nbsp;&nbsp;In addition to the underwriting
discount, CGMI and its affiliates may profit from hedging activity related to this offering, even if the value of the notes declines.&nbsp;&nbsp;See
&ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-indent: 0in; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Citigroup
    Global Markets Inc.</B></FONT></TD>
    <TD STYLE="text-align: right; width: 50%; text-indent: 0in; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>UBS
    Financial Services Inc.</B></FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Additional Terms Specific to the Notes</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the notes are set forth in the accompanying product supplement,
prospectus supplement and prospectus, as supplemented by this pricing supplement.&nbsp;&nbsp;The accompanying product supplement, prospectus
supplement and prospectus contain important disclosures that are not repeated in this pricing supplement.&nbsp;&nbsp;For example, certain
events may occur that could affect whether you receive a contingent coupon payment on a coupon payment date and whether you are repaid
the stated principal amount of your notes at maturity.&nbsp;&nbsp;These events and their consequences are described in the accompanying
product supplement in the sections &ldquo;Description of the Securities&mdash;Consequences of a Market Disruption Event; Postponement
of a Valuation Date&rdquo; and &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying
Index&mdash;Discontinuance or Material Modification of an Underlying Index,&rdquo; and not in this pricing supplement.&nbsp;&nbsp;The
accompanying underlying supplement contains important disclosures regarding the underlyings that are not repeated in this pricing supplement.&nbsp;&nbsp;It
is important that you read the accompanying product supplement, underlying supplement, prospectus supplement and prospectus together with
this pricing supplement in connection with your investment in the notes.&nbsp;&nbsp;Certain terms used but not defined in this pricing
supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You may access the accompanying product supplement, underlying supplement,
prospectus supplement and prospectus on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings
for the relevant dates on the SEC website):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>Product Supplement No. EA-04-10 dated March 7, 2023:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0in"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm">https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>Underlying Supplement No. 11 dated March 7, 2023:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0in"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm">https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>Prospectus Supplement and Prospectus each dated March 7, 2023:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0in"><A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm">https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">References to &ldquo;Citigroup Global Markets Holdings Inc.,&rdquo;
&ldquo;Citigroup,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; and &ldquo;us&rdquo; refer to Citigroup Global Markets Holdings Inc. and
not to any of its subsidiaries.&nbsp;&nbsp;References to &ldquo;Citigroup Inc.&rdquo; refer to Citigroup Inc. and not to any of its subsidiaries.&nbsp;&nbsp;In
this pricing supplement, &ldquo;notes&rdquo; refers to the Trigger Callable Contingent Yield Notes Linked to the Least Performing of the
S&amp;P 500<SUP>&reg;</SUP> Index, the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index that are offered hereby,
unless the context otherwise requires.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>This pricing supplement, together with the documents listed above,
contains the terms of the notes and supersedes all other prior or contemporaneous oral statements as well as any other written materials
including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures
or other educational materials of ours.&nbsp;&nbsp;The description in this pricing supplement of the particular terms of the notes supplements,
and, to the extent inconsistent with, replaces, the descriptions of the general terms and provisions of the debt securities set forth
in the accompanying product supplement, prospectus supplement and prospectus.&nbsp;&nbsp;You should carefully consider, among other things,
the matters set forth in &ldquo;Summary Risk Factors&rdquo; in this pricing supplement and &ldquo;Risk Factors Relating to the Securities&rdquo;
in the accompanying product supplement, as the notes involve risks not associated with conventional debt securities.&nbsp;&nbsp;We urge
you to consult your investment, legal, tax, accounting and other advisers in connection with your decision to invest in the notes.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Investor Suitability</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The suitability considerations identified below are not exhaustive.&nbsp;&nbsp;Whether
or not the notes are a suitable investment for you will depend on your individual circumstances, and you should reach an investment decision
only after you and your investment, legal, tax, accounting and other advisors have carefully considered the suitability of an investment
in the notes in light of your particular circumstances. You should also review &ldquo;Summary Risk Factors&rdquo; beginning on page PS-7
of this pricing supplement, &ldquo;The S&amp;P 500<SUP>&reg;</SUP> Index&rdquo; beginning on page PS-14 of this pricing supplement, &ldquo;The
Nasdaq-100 Index<SUP>&reg;</SUP>&ldquo; beginning on page PS-15 of this pricing supplement, &ldquo;The Russell 2000<SUP>&reg;</SUP> Index&ldquo;
beginning on page PS-16 of this pricing supplement, &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 of the
accompanying product supplement, &ldquo;Equity Index Descriptions&mdash;The S&amp;P U.S. Indices&rdquo; beginning on page US-58 of the
accompanying underlying supplement, &ldquo;Equity Index Descriptions&mdash;The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; beginning on page
US-26 of the accompanying underlying supplement and &ldquo;Equity Index Descriptions&mdash; <FONT STYLE="background-color: white">The
Russell Indices&rdquo; beginning on page US-37</FONT> of the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>The notes may be suitable for you if, among other considerations:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You fully understand the risks inherent in an investment in the notes, including the risk of loss of your entire initial investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You can tolerate a loss of all or a substantial portion of your initial investment and are willing to make an investment that may
have the full downside market risk of an investment in the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You understand and accept the risks associated with each of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the closing level of each underlying is likely to be greater than or equal to its coupon barrier on each trading day during
the quarterly observation periods, and, if the closing level of any underlying is not, you can tolerate receiving few or no contingent
coupon payments over the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the final underlying level of each underlying will be greater than or equal to its downside threshold, and, if the final
underlying level of any underlying is below its downside threshold, you can tolerate a loss of all or a substantial portion of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You can tolerate fluctuations in the value of the notes prior to maturity that may be similar to or exceed the downside fluctuations
in the level of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to accept the individual market risk of each underlying on each trading day during the quarterly observation periods
and on the final valuation date, and you understand that any decline in the level of one underlying will not be offset or mitigated by
a lesser decline or any potential increase in the levels of the other underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to hold notes that may be called early by the issuer in its sole discretion regardless of the closing level of any
underlying, and you are otherwise willing to hold such notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to make an investment whose positive return is limited to the contingent coupon payments, regardless of the potential
appreciation of the underlyings, which could be significant.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to invest in the notes based on the contingent coupon rate indicated on the cover page of this pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to invest in the notes based on the coupon barriers and downside thresholds indicated on the cover page of this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing and able to hold the notes to maturity, and accept that there may be little or no secondary market for the notes and
that any secondary market will depend in large part on the price, if any, at which CGMI is willing to purchase the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not seek guaranteed current income from your investment and are willing to forgo dividends or any other distributions paid
on the stocks included in the underlyings for the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><FONT STYLE="font-size: 10pt">You
                                            are willing to assume the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup
                                            Inc. for all payments under the notes, and understand that if Citigroup Global Markets Holdings
                                            Inc. and Citigroup Inc. default on their obligations, you might not receive any amounts due
                                            to you, including any repayment of the stated principal amount.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt"></P>

</DIV>

<DIV STYLE="float: right; width: 49%">

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>The notes may <I>not</I> be suitable for you if, among
other considerations:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not fully understand the risks inherent in an investment in the notes, including the risk of loss of your entire initial investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You cannot tolerate the loss of all or a substantial portion of your initial investment, or you are not willing to make an investment
that may have the full downside market risk of an investment in the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not understand or are not willing to accept the risks associated with each of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not believe the closing level of each underlying is likely to be greater than or equal to its coupon barrier on each trading
day during the quarterly observation periods, or you cannot tolerate receiving few or no contingent coupon payments over the term of the
notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the final underlying level of at least one underlying will be less than its downside threshold, exposing you to the full
downside performance of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You require an investment designed to guarantee a full return of the stated principal amount at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You cannot tolerate fluctuations in the value of the notes prior to maturity that may be similar to or exceed the downside fluctuations
in the level of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to accept the individual market risk of each underlying on each trading day during the quarterly observation periods
and on the final valuation date, or you seek an investment based on the performance of a basket composed of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to hold notes that may be called early by the issuer in its sole discretion regardless of the closing level of any
underlying, or you are otherwise unable or unwilling to hold such notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek an investment that participates in the full appreciation of the underlyings and whose positive return is not limited to the
contingent coupon payments.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to invest in the notes based on the contingent coupon rate indicated on the cover page of this pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to invest in the notes based on the coupon barriers and downside thresholds indicated on the cover page of this
pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek an investment for which there will be an active secondary market.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek guaranteed current income from this investment or prefer to receive the dividends and any other distributions paid on the
stocks included in the underlyings for the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You prefer the lower risk of conventional fixed income investments with comparable maturities and credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are not willing to assume the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. for all payments under
the notes, including any repayment of the stated principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; color: white"><B>Final Terms</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37%"><FONT STYLE="font-size: 10pt">Issuer</FONT></TD>
    <TD STYLE="width: 63%"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Guarantee</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">All payments due on the notes are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Issue price</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">100% of the stated principal amount per note</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Stated principal amount per note</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$10.00 per note</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Term</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Approximately 3.25 years, unless called earlier</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Strike date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">October 13, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Trade date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">October 15, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Settlement date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">October 17, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Final valuation date<SUP>1</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">January 16, 2029</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Maturity date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">January 18, 2029</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Underlyings</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">S&amp;P 500<SUP>&reg;</SUP> Index (Ticker: SPX)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">Nasdaq-100 Index<SUP>&reg;</SUP> (Ticker: NDX)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">Russell 2000<SUP>&reg;</SUP> Index (Ticker: RTY)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Issuer call feature</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">The issuer may, in its sole discretion, call the notes in
    whole, but not in part, on any coupon payment date prior to the maturity date upon not less than two (2) business days&rsquo; notice prior
    to such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">If the notes are called, we will pay you on the applicable
    coupon payment date a cash payment per $10.00 stated principal amount of each note equal to the stated principal amount per note plus
    any contingent coupon otherwise due on such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">After the notes are called, no further payments will be made
    on the notes.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Observation period</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Each observation period will consist of each trading day from, but excluding, an observation period end date to, and including, the following observation period end date; <I>provided</I> that the first observation period will consist of each trading day from, but excluding, the trade date to, and including, the first observation period end date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Observation period end dates</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">See &ldquo;Observation Period End Dates/Coupon Payment Dates for the Offering of the Notes&rdquo; on page PS-6.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Trading day</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying index, a scheduled trading day for that underlying index on which a market disruption event has not occurred with respect to that underlying index.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Coupon payment dates</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">See &ldquo;Observation Period End Dates/Coupon Payment Dates for the Offering of the Notes&rdquo; on page PS-6.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">_______________________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-indent: -0.125in; padding-left: 0.125in"><SUP>1</SUP> Subject to postponement as described under &ldquo;Description of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Valuation Date&rdquo; in the accompanying product supplement.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: right; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 37%"><FONT STYLE="font-size: 10pt">Contingent coupon/contingent coupon rate</FONT></TD>
    <TD STYLE="width: 63%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">If the closing levels of <B>all</B> the underlyings on each
    trading day during the applicable observation period are greater than or equal to their respective coupon barriers, we will make a contingent
    coupon payment with respect to that observation period on the related coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">However, if the closing level of <B>any</B> underlying on
    <B>any</B> trading day during the applicable observation period is less than its coupon barrier, no contingent coupon will be payable
    on the related coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">Each contingent coupon payment will be in the amount of $0.28
    for each $10.00 stated principal amount note (based on the per annum contingent coupon rate of 11.20%) and will be payable with respect
    to each observation period in which the closing levels of <B>all</B> the underlyings on each trading day during that observation period
    are greater than or equal to their respective coupon barriers.&nbsp;&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"><B>Contingent coupon payments on the notes are not guaranteed.
    We will not pay you the contingent coupon for any observation period in which the closing level of <U>any</U> underlying on <U>any</U>
    trading day is less than its coupon barrier. </B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Payment at maturity (per $10.00 stated principal amount of notes)</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not called prior to maturity and the final underlying
    level of the least performing underlying is greater than or equal to its downside threshold</B>, we will pay you the $10.00 stated principal
    amount plus any contingent coupon otherwise due on the maturity date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not called prior to maturity and the final underlying
    level of the least performing underlying is less than its downside threshold, </B>we will pay you a cash payment on the maturity date
    that is less than your stated principal amount and may be zero, resulting in a loss that is proportionate to the negative underlying return
    of the least performing underlying, equal to:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-decoration: none double; color: Black">$10.00</FONT>
    &times; (1 + underlying return of the least performing underlying)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Accordingly, you may lose all or a substantial portion of your
    stated principal amount at maturity, depending on how significantly the least performing underlying declines.</I></B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Least performing underlying</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The underlying with the lowest underlying return.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Underlying return</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For each underlying, calculated as follows:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><U>final underlying level &ndash; initial underlying
    level<BR>
    </U>initial underlying level</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Downside threshold</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying, 60.00% of its respective initial underlying level, as specified on the cover of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Coupon barrier</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying, 70.00% of its respective initial underlying level, as specified on the cover of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Initial underlying level</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying, its closing level on the strike date, as specified on the cover page of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Final underlying level</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any underlying, its closing level on the final valuation date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>INVESTING IN THE NOTES INVOLVES SIGNIFICANT RISKS. YOU MAY LOSE&nbsp;A SUBSTANTIAL PORTION OR ALL OF YOUR INITIAL INVESTMENT.&nbsp;THE CONTINGENT REPAYMENT OF THE STATED PRINCIPAL AMOUNT APPLIES ONLY IF YOU HOLD THE NOTES TO MATURITY. ANY PAYMENT ON THE NOTES IS SUBJECT TO THE CREDITWORTHINESS OF THE ISSUER AND THE GUARANTOR. IF CITIGROUP GLOBAL MARKETS HOLDINGS INC. AND CITIGROUP INC. WERE TO DEFAULT ON THEIR OBLIGATIONS, YOU MIGHT NOT RECEIVE ANY AMOUNTS OWED TO YOU UNDER THE NOTES AND YOU COULD LOSE YOUR ENTIRE INVESTMENT.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 50%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="5" STYLE="vertical-align: top; background-color: #788D41"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT><FONT STYLE="font-size: 10pt; color: white"><B>Investment Timeline</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; background-color: white; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #DEDFB3; text-align: center"><FONT STYLE="font-size: 10pt"><B>Strike date</B></FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">The closing level of each underlying (its respective initial underlying level) is observed and the coupon barrier and downside threshold for each underlying are determined.&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><IMG SRC="image_001.jpg" ALT=""></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #DEDFB3; text-align: center"><FONT STYLE="font-size: 10pt"><B>Trade date</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">The contingent coupon rate is set.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><IMG SRC="image_002.jpg" ALT=""><FONT STYLE="font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #DEDFB3">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Quarterly</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>(callable by the issuer in its sole discretion)</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">If the closing levels of <B>all</B> the underlyings on each
    trading day during the applicable observation period are greater than or equal to their respective coupon barriers, we will make a contingent
    coupon payment with respect to that observation period on the related coupon payment date. However, if the closing level of <B>any</B>
    underlying on <B>any</B> trading day during the applicable observation period is less than its coupon barrier, no contingent coupon will
    be payable on the related coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">The issuer may, in its sole discretion, call the notes in
    whole, but not in part, on any coupon payment date prior to the maturity date upon not less than two (2) business days&rsquo; notice prior
    to such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">If the notes are called, we will pay you on the applicable
    coupon payment date a cash payment per $10.00 stated principal amount of each note equal to the stated principal amount per note plus
    any contingent coupon otherwise due on such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">After the notes are called, no further payments will be made
    on the notes.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><IMG SRC="image_003.jpg" ALT=""><FONT STYLE="font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #DEDFB3; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maturity date (if not previously called)</B></FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">If the notes are not called prior to maturity, the final underlying
    level of each underlying is observed on the final valuation date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not called prior to maturity and the final underlying
    level of the least performing underlying is greater than or equal to its downside threshold</B>, we will pay you the $10.00 stated principal
    amount plus any contingent coupon otherwise due on the maturity date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not called prior to maturity and the final underlying
    level of the least performing underlying is less than its downside threshold,<BR>
    </B>we will pay you a cash payment on the maturity date that is less than your stated principal amount and may be zero, resulting in a
    loss that is proportionate to the negative underlying return of the least performing underlying, equal to:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-decoration: none double">$10.00</FONT>
    &times; (1 + underlying return of the least<BR>
    performing underlying)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0"><B><I>Accordingly, you may lose all or a substantial portion
of your stated principal amount at maturity, depending on how significantly the least performing underlying declines. </I></B></P></TD></TR>
  <TR>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 29%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 64%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid">Observation
Period End Dates/Coupon Payment Dates for the Offering of the Notes</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: black"><B>Observation Period End Dates</B></FONT></TD>
    <TD STYLE="width: 48%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: black"><B>Coupon Payment Dates</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 15, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 20, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 15, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 17, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 15, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 17, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 15, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 19, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 15, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 20, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 15, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 19, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 15, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 19, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 15, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 19, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 18, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 20, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 17, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 19, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 17, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 19, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 16, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 18, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 16, 2029</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 18, 2029</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Summary Risk Factors</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the notes is significantly riskier than an investment
in conventional debt securities.&nbsp;&nbsp;The notes are subject to all of the risks associated with an investment in our conventional
debt securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the
notes, and are also subject to risks associated with each underlying.&nbsp;&nbsp;Accordingly, the notes are suitable only for investors
who are capable of understanding the complexities and risks of the notes.&nbsp;&nbsp;You should consult your own financial, tax and legal
advisers as to the risks of an investment in the notes and the suitability of the notes in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the notes.&nbsp;&nbsp;You should read this summary together with the more detailed description of risks relating to an investment in
the notes contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement.&nbsp;&nbsp;You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents
incorporated by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and
any subsequent Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You may lose some or all of your investment </B>&mdash; The notes differ from ordinary debt securities in that we will not necessarily
repay the full stated principal amount of your notes at maturity.&nbsp;&nbsp;If the notes are not called prior to maturity and the final
underlying level of the least performing underlying is less than its downside threshold, you will lose 1% of the stated principal amount
of the notes for every 1% by which the final underlying level of the least performing underlying is less than its initial underlying level.&nbsp;&nbsp;There
is no minimum payment at maturity on the notes, and you may lose up to all of your investment in the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will not receive any contingent coupon payment for any quarter in which the closing level of any underlying on any trading
day during the related observation period is less than its coupon barrier</B> &mdash; A contingent coupon payment will be made on a coupon
payment date if and only if the closing levels of all the underlyings on each trading day during the applicable observation period are
greater than or equal to their respective coupon barriers. If the closing level of any underlying on any trading day during an observation
period is less than its coupon barrier, you will not receive any contingent coupon payment on the related coupon payment date. If the
closing level of any underlying is below its coupon barrier on at least one trading day during each quarterly observation period, you
will not receive any contingent coupon payments over the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes are subject to the risks of each of the underlyings and will be negatively affected if any underlying performs poorly,
even if the other underlyings perform well </B>&mdash; You are subject to risks associated with each of the underlyings. If any underlying
performs poorly, you will be negatively affected, even if the other underlyings perform well. The notes are not linked to a basket composed
of the underlyings, where the better performance of one could ameliorate the poor performance of the others. Instead, you are subject
to the full risks of each individual underlying. Furthermore, the risk that you will not receive the contingent coupon and that you will
lose some or all of your initial investment in the notes is greater if you invest in the notes as opposed to notes that are linked to
the performance of a single underlying if their terms are otherwise substantially similar.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will not benefit in any way from the performance of the better performing underlyings </B>&mdash; The payment at maturity depends
solely on the performance of the least performing underlying, and you will not benefit in any way from the performance of the better performing
underlyings.&nbsp;&nbsp;The notes may underperform a similar investment in all of the underlyings or a similar alternative investment
linked to a basket composed of the underlyings, since in either such case the performance of the better performing underlyings would be
blended with the performance of the least performing underlying, resulting in a better return than the return of the least performing
underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will be subject to risks relating to the relationship between the underlyings</B> &mdash; It is preferable from your perspective
for the underlyings to be correlated with each other, in the sense that they tend to increase or decrease at similar times and by similar
magnitudes.&nbsp;&nbsp;By investing in the notes, you assume the risk that the underlyings will not exhibit this relationship.&nbsp;&nbsp;The
less correlated the underlyings, the more likely it is that either one of the underlyings will perform poorly over the term of the notes.
All that is necessary for the notes to perform poorly is for one of the underlyings to perform poorly; the performance of the better performing
underlyings are not relevant to your return on the notes.&nbsp;&nbsp;It is impossible to predict what the relationship between the underlyings
will be over the term of the notes.&nbsp;&nbsp;<B>The S&amp;P 500<SUP>&reg; </SUP>Index represents large capitalization stocks in the
United States, the Nasdaq-100 Index<SUP>&reg;</SUP> represents 100 of the largest non-financial companies listed on the Nasdaq Stock Market
and the Russell 2000<SUP>&reg; </SUP>Index represents small capitalization stocks in the United States.&nbsp;&nbsp;Accordingly, the underlyings
represent markets that differ in significant ways and, therefore, may not be correlated with each other.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Higher contingent coupon rates are associated with greater risk</B> &mdash; The notes offer contingent coupon payments at an annualized
rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same
maturity. This higher potential yield is associated with greater levels of expected risk as of the trade date for the notes, including
the risks that you may not receive a contingent coupon payment on one or more, or any, coupon payment dates, the notes will not be called
and the amount you receive at maturity may be significantly less than the stated principal amount of your notes and may be zero. The volatility
of and the correlation between the underlyings are important factors affecting these risks. Greater expected volatility of, and lower
expected correlation between, the underlyings as of the trade date may result in a higher contingent coupon rate, but would also represent
a greater expected likelihood as of the trade date that (i) the closing level of at least one underlying will be less than its coupon
barrier on at least one trading day during one or more observation periods, such that you will not receive one or more, or any, contingent
coupon payments during the term of the notes and that (ii) the closing level of the least performing underlying will be less than the
applicable downside threshold on the final valuation date, such that you will not be repaid the stated principal amount of your notes
at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You may not be adequately compensated for assuming the downside risk of the least performing underlying</B> &mdash; The potential
contingent coupon payments on the notes are the compensation you receive for assuming the downside risk of the least performing underlying,
as well as all the other risks of the notes. That compensation is effectively &ldquo;at risk&rdquo; and may, therefore, be less than you
currently anticipate. First, the actual yield you realize on the notes could be lower than you anticipate because the coupon is &ldquo;contingent&rdquo;
and you may not receive a contingent coupon payment on one or more, or any, of the coupon payment dates. Second, the contingent coupon
payments are the compensation you receive not only for the downside risk of the least performing underlying, but also for all of the other
risks of the notes, including the risk that the notes may be called prior to maturity, interest rate risk and our and Citigroup Inc.&rsquo;s
credit risk. If those other risks increase or are otherwise greater than you currently anticipate, the contingent coupon payments may
turn out to be inadequate to compensate you for all the risks of the notes, including the downside risk of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>We may call the notes in our sole discretion, which will limit your ability to receive the contingent coupon payments</B> &mdash;
We may call the notes on any coupon payment date prior to the maturity date upon not less than two (2) business days&rsquo; notice. In
the event that we call the notes, you will receive the stated principal amount of your notes and any contingent coupon otherwise due on
such coupon payment date.&nbsp;&nbsp;Thus, the term of the notes may be limited to as short as approximately three months.&nbsp;&nbsp;If
we call the notes prior to maturity, you will not receive any additional contingent coupon payments.&nbsp;&nbsp;It is more likely that
we will call the notes in our sole discretion prior to maturity to the extent that the expected coupon payable on the notes is greater
than the coupon that would be payable on other instruments issued by us of comparable maturity, terms and credit rating trading in the
market. The greater likelihood of us calling the notes in that environment increases the risk that you will not be able to reinvest the
proceeds from the called notes in an another investment that provides a similar yield with a similar level of risk.&nbsp;&nbsp;We are
less likely to call the notes prior to maturity when the expected contingent coupon payable on the notes is less than the coupon that
would be payable on other comparable instruments issued by us, which includes when the level of any of the underlyings is less than its
coupon barrier. Therefore, the notes are more likely to remain outstanding when the expected contingent coupon payable on the notes is
less than what would be payable on other comparable instruments and when your risk of not receiving a contingent coupon is relatively
higher.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes offer downside exposure to the least performing underlying, but no upside exposure to any underlying</B> &mdash; You
will not participate in any appreciation in the level of the underlyings over the term of the notes. Consequently, your return on the
notes will be limited to the contingent coupon payments you receive, if any, and may be significantly less than the return on the underlyings
over the term of the notes. In addition, you will not receive any dividends or other distributions or have any other rights with respect
to the underlyings or the stocks included in the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The payment at maturity depends on the closing level of the least performing underlying on a single day</B> &mdash; If the closing
level of the least performing underlying on the final valuation date is less than its downside threshold, you will not receive the full
stated principal amount of your notes at maturity, even if the closing level of the least performing underlying is greater than its downside
threshold on other dates during the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Investing in the notes is not equivalent to investing in any underlying or the stocks that constitute any underlying</B> &mdash;
You will not have voting rights, rights to receive any dividends or other distributions or any other rights with respect to any of the
stocks that constitute the underlyings.&nbsp;&nbsp;It is important to understand that, for purposes of measuring the performance of the
underlyings, the levels used will not reflect the receipt or reinvestment of dividends or distributions on the stocks that constitute
any underlying.&nbsp;&nbsp;Dividend or distribution yield on the stocks that constitute the underlyings would be expected to represent
a significant portion of the overall return on a direct investment in the stocks that constitute the underlyings, but will not be reflected
in the performance of any underlying as measured for purposes of the notes (except to the extent that dividends and distributions reduce
the levels of the underlyings).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. </B>&mdash; Any payment on
the notes will be made by Citigroup Global Markets Holdings Inc. and is guaranteed by Citigroup Inc., and therefore is subject to the
credit risk of both Citigroup Global Markets Holdings Inc. and Citigroup Inc. If we default on our obligations under the notes and Citigroup
Inc. defaults on its guarantee obligations, you may not receive any payments that become due under the notes.&nbsp;&nbsp;As a result,
the value of the notes prior to maturity will be affected by changes in the market&rsquo;s view of our and Citigroup Inc.&rsquo;s creditworthiness.&nbsp;&nbsp;Any
decline, or anticipated decline, in either of our or Citigroup Inc.&rsquo;s credit ratings or increase, or anticipated increase, in the
credit spreads charged by the market for taking either of our or Citigroup Inc.&rsquo;s credit risk is likely to adversely affect the
value of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes will not be listed on any securities exchange and you may not be able to sell them prior to maturity</B> &mdash; The
notes will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the notes.&nbsp;&nbsp;CGMI
currently intends to make a secondary market in relation to the notes and to provide an indicative bid price for the notes on a daily
basis. Any indicative bid price for the notes provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the notes can be sold at that price,
or at all.&nbsp;&nbsp;CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and
for any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the notes because it is likely
that CGMI will be the only broker-dealer that is willing to buy your notes prior to maturity.&nbsp;&nbsp;Accordingly, an investor must
be prepared to hold the notes until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The probability that any underlying will fall below its coupon barrier on any trading day during any observation period or the
least performing underlying will fall below its downside threshold on the final valuation date will depend in part on the volatility of,
and correlation between, the underlyings </B>&mdash; &ldquo;Volatility&rdquo; refers to the frequency and magnitude of changes in the
level of the underlyings.&nbsp;&nbsp;&ldquo;Correlation&rdquo; refers to the extent to which the underlyings tend to increase or decrease
at similar times and by similar magnitudes.&nbsp;&nbsp;In general, the greater the volatility of the underlyings, and the lower the correlation
between the underlyings, the greater the probability that at least one of the underlyings will experience a large decline over the term
of the notes and fall below its</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt">respective coupon barrier on one, or
more, trading days during one, or more, observation periods and/or below its downside threshold on the final valuation date.&nbsp;&nbsp;The
underlyings have historically experienced significant volatility, and as discussed above, the underlyings represent markets that differ
in significant ways and therefore may not be correlated.&nbsp;&nbsp;As a result, there is a significant risk that at least one of the
underlyings will fall below its coupon barrier on one or more trading days, such that you will not receive one or more contingent coupon
payments, and that at least one of the underlyings will fall below its downside threshold on the final valuation date, such that you will
incur a significant loss on your investment in the notes.&nbsp;&nbsp;The terms of the notes are set, in part, based on expectations about
the volatility of, and correlation between, the underlyings as of the strike date.&nbsp;&nbsp;If expectations about the volatility of,
and correlation between, the underlyings change over the term of the notes, the value of the notes may be adversely affected, and if the
actual volatility of the underlyings prove to be greater than initially expected, or if the actual correlation between the underlyings
proves to be lower than initially expected, the notes may prove to be riskier than expected on the strike date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>The estimated value of the notes on the trade date, based on CGMI&rsquo;s proprietary pricing models
and our internal funding rate, is less than the issue price</B></FONT> &mdash; <FONT STYLE="font-size: 10pt">The difference is attributable
to certain costs associated with selling, structuring and hedging the notes that are included in the issue price.&nbsp;&nbsp;These costs
include (i) the underwriting discount paid in connection with the offering of the notes, (ii) hedging and other costs incurred by us and
our affiliates in connection with the offering of the notes and (iii) the expected profit (which may be more or less than actual profit)
to CGMI or other of our affiliates in connection with hedging our obligations under the notes.&nbsp;&nbsp;These costs adversely affect
the economic terms of the notes because, if they were lower, the economic terms of the notes would be more favorable to you.&nbsp;&nbsp;The
economic terms of the notes are also likely to be adversely affected by the use of our internal funding rate, rather than our secondary
market rate, to price the notes.&nbsp;&nbsp;See &ldquo;The estimated value of the notes would be lower if it were calculated based on
our secondary market rate&rdquo; below.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes was determined for us by our affiliate using proprietary pricing models </B>&mdash; CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models.&nbsp;&nbsp;In doing so,
it may have made discretionary judgments about the inputs to its models, such as the volatility of and correlation between the underlyings,
dividend yields on the stocks that constitute the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ from your
or others&rsquo; views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours.&nbsp;&nbsp;Both the models
and the inputs to the models may prove to be wrong and therefore not an accurate reflection of the value of the notes.&nbsp;&nbsp;Moreover,
the estimated value of the notes set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates
may determine for the notes for other purposes, including for accounting purposes.&nbsp;&nbsp;You should not invest in the notes because
of the estimated value of the notes.&nbsp;&nbsp;Instead, you should be willing to hold the notes to maturity irrespective of the initial
estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes would be lower if it were calculated based on our secondary market rate </B>&mdash; The estimated
value of the notes included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which we
are willing to borrow funds through the issuance of the notes.&nbsp;&nbsp;Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the notes for purposes of any purchases of the notes from
you in the secondary market.&nbsp;&nbsp;If the estimated value included in this pricing supplement were based on our secondary market
rate, rather than our internal funding rate, it would likely be lower.&nbsp;&nbsp;We determine our internal funding rate based on factors
such as the costs associated with the notes, which are generally higher than the costs associated with conventional debt securities, and
our liquidity needs and preferences.&nbsp;&nbsp;Our internal funding rate is not the same as the contingent coupon rate that is payable
on the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Because there is not an active market for
traded instruments referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of
traded instruments referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the
notes, but subject to adjustments that CGMI makes in its sole discretion.&nbsp;&nbsp;As a result, our secondary market rate is not a market-determined
measure of our creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted
for discretionary factors such as CGMI&rsquo;s preferences with respect to purchasing the notes prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes is not an indication of the price, if any, at which CGMI or any other person may be willing to
buy the notes from you in the secondary market</B> &mdash; Any such secondary market price will fluctuate over the term of the notes based
on the market and other factors described in the next risk factor.&nbsp;&nbsp;Moreover, unlike the estimated value included in this pricing
supplement, any value of the notes determined for purposes of a secondary market transaction will be based on our secondary market rate,
which will likely result in a lower value for the notes than if our internal funding rate were used.&nbsp;&nbsp;In addition, any secondary
market price for the notes will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount of the
notes to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.&nbsp;&nbsp;As
a result, it is likely that any secondary market price for the notes will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The value of the notes prior to maturity will fluctuate based on many unpredictable factors </B>&mdash; As described under &ldquo;Valuation
of the Notes&rdquo; below, the payout on the notes could be replicated by a hypothetical package of financial instruments consisting of
a fixed-income bond and one or more derivative instruments.&nbsp;&nbsp;As a result, the factors that influence the values of fixed-income
bonds and derivative instruments will also influence the terms of the notes at issuance and the value of the notes prior to maturity.&nbsp;&nbsp;Accordingly,
the value of your notes prior to maturity will fluctuate based on the level and volatility of the underlyings and a number of other factors,
including the price and volatility of the stocks that constitute the underlyings, the correlation between the underlyings, dividend yields
on the stocks that constitute the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s
creditworthiness, as reflected in our secondary market rate.&nbsp;&nbsp;Changes in the levels of the underlyings may not result in a comparable
change in the value of your notes.&nbsp;&nbsp;You should understand that the value of your notes at any time prior to maturity may be
significantly less than the issue price.&nbsp;&nbsp;The stated payout from the issuer only applies if you hold the notes to maturity or
earlier issuer call, as applicable.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Russell 2000<SUP>&reg; </SUP>Index is subject to risks associated with small capitalization
stocks </B>&mdash; The stocks that constitute the Russell 2000<SUP>&reg;</SUP> Index are issued by companies with relatively small market
capitalization.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>The stock prices of smaller companies may be
more volatile than the stock prices of large capitalization companies.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>These
companies tend to be less well-established than large market capitalization companies.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>Small
capitalization companies may be less able to withstand adverse economic, market, trade and competitive conditions relative to larger companies.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>Small
capitalization companies are less likely to pay dividends on their stocks, and the presence of a dividend payment could be a factor that
limits downward stock price pressure under adverse market conditions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The Nasdaq-100 Index<SUP>&reg;</SUP> is subject to risks associated with the stocks of foreign companies</B> &mdash; Some of the
stocks that constitute the Nasdaq-100 Index<SUP>&reg;</SUP> are issued by foreign companies.&nbsp;&nbsp;Investments in securities of foreign
companies involve risks associated with those countries, including risks of governmental intervention and cross-shareholdings in companies
in certain countries.&nbsp;&nbsp;The prices of securities issued by foreign companies may be affected by political, economic, financial
and social factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange
laws.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment</B> &mdash; The amount of this temporary
upward adjustment will decline to zero over the temporary adjustment period.&nbsp;&nbsp;See &ldquo;Valuation of the Notes&rdquo; in this
pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our offering of the notes is not a recommendation of any underlying </B>&mdash; The fact that we are offering the notes does not
mean that we believe that investing in an instrument linked to the least performing of the underlyings is likely to achieve favorable
returns. In fact, as we are part of a global financial institution, our affiliates may have positions (including short positions) in the
stocks that constitute the underlyings or in instruments related to the underlyings or such stocks, and may publish research or express
opinions, that in each case are inconsistent with an investment linked to the underlyings. These and other activities of our affiliates
may affect the levels of the underlyings in a way that has a negative impact on your interests as a holder of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our affiliates, or UBS or its affiliates, may publish research, express opinions or provide recommendations that are inconsistent
with investing in or holding the notes</B> &mdash; Any such research, opinions or recommendations could affect the closing levels of the
underlyings and the value of the notes.&nbsp;&nbsp;Our affiliates, and UBS and its affiliates, publish research from time to time on financial
markets and other matters that may influence the value of the notes, or express opinions or provide recommendations that may be inconsistent
with purchasing or holding the notes.&nbsp;&nbsp;Any research, opinions or recommendations expressed by our affiliates or by UBS or its
affiliates may not be consistent with each other and may be modified from time to time without notice.&nbsp;&nbsp;These and other activities
of our affiliates or UBS or its affiliates may adversely affect the levels of the underlyings and may have a negative impact on your interests
as a holder of the notes.&nbsp;&nbsp;Investors should make their own independent investigation of the merits of investing in the notes
and the underlyings to which the notes are linked.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Trading and other transactions by our affiliates, or by UBS or its affiliates, in the equity and equity derivative markets may
impair the value of the notes </B>&mdash; We have hedged our exposure under the notes through CGMI or other of our affiliates, who have
entered into equity and/or equity derivative transactions, such as over-the-counter options or exchange-traded instruments, relating to
the underlyings or the stocks included in the underlyings and may adjust such positions during the term of the notes.&nbsp;&nbsp;It is
possible that our affiliates could receive substantial returns from these hedging activities while the value of the notes declines.&nbsp;&nbsp;Our
affiliates and UBS and its affiliates may also engage in trading in instruments linked to the underlyings on a regular basis as part of
their respective general broker-dealer and other businesses, for proprietary accounts, for other accounts under management or to facilitate
transactions for customers, including block transactions.&nbsp;&nbsp;Such trading and hedging activities may affect the levels of the
underlyings and reduce the return on your investment in the notes.&nbsp;&nbsp;Our affiliates or UBS or its affiliates may also issue or
underwrite other securities or financial or derivative instruments with returns linked or related to the underlyings.&nbsp;&nbsp;By introducing
competing products into the marketplace in this manner, our affiliates or UBS or its affiliates could adversely affect the value of the
notes.&nbsp;&nbsp;Any of the foregoing activities described in this paragraph may reflect trading strategies that differ from, or are
in direct opposition to, investors&rsquo; trading and investment strategies relating to the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our affiliates, or UBS or its affiliates, may have economic interests that are adverse to yours as a result of their respective
business activities </B>&mdash; Our affiliates or UBS or its affiliates may currently or from time to time engage in business with the
issuers of the stocks that constitute the underlyings, including extending loans to, making equity investments in or providing advisory
services to such issuers. In the course of this business, our affiliates or UBS or its affiliates may acquire non-public information about
those issuers, which they will not disclose to you. Moreover, if any of our affiliates or UBS or any of its affiliates is or becomes a
creditor of any such issuer, they may exercise any remedies against that issuer that are available to them without regard to your interests.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the notes </B>&mdash;
If certain events occur, such as market disruption events or the discontinuance of an underlying, CGMI, as calculation agent, will be
required to make discretionary judgments that could significantly affect the payments on the notes. Such judgments could include, among
other things:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>determining whether a market disruption event has occurred with respect to an underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>if a market disruption event occurs on the final valuation date with respect to an underlying, determining whether to postpone the
final valuation date;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>determining the levels of the underlyings if the levels of the underlyings are not otherwise available or a market disruption event
has occurred; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>selecting a successor underlying or performing an alternative calculation of the level of an underlying if an underlying is discontinued
or materially modified (see &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying
Index&mdash;Discontinuance or Material Modification of an Underlying Index&rdquo; in the accompanying product supplement).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">In making these judgments, the calculation agent&rsquo;s
interests as an affiliate of ours could be adverse to your interests as a holder of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Adjustments to any underlying may affect the value of your notes</B> &mdash; S&amp;P Dow Jones Indices LLC, as publisher of the
S&amp;P 500<SUP>&reg;</SUP> Index, Nasdaq, Inc., as publisher of the Nasdaq-100 Index, or <FONT STYLE="background-color: white">FTSE Russell,
as publisher of the Russell 2000<SUP>&reg;</SUP> Index,</FONT> may add, delete or substitute the stocks that constitute any underlying
or make other methodological changes that could affect the level of any underlying. S&amp;P Dow Jones Indices LLC, Nasdaq, Inc. or FTSE
Russell may discontinue or suspend calculation or publication of any underlying at any time without regard to your interests as holders
of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the notes are unclear </B>&mdash; There is no direct legal authority regarding
the proper U.S. federal tax treatment of the notes, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;).&nbsp;&nbsp;Consequently,
significant aspects of the tax treatment of the notes are uncertain, and the IRS or a court might not agree with the treatment of the
notes as described in &ldquo;United States Federal Tax Considerations&rdquo; below.&nbsp;&nbsp;If the IRS were successful in asserting
an alternative treatment of the notes, the tax consequences of the ownership and disposition of the notes might be materially and adversely
affected.&nbsp;&nbsp;Moreover, future legislation, Treasury regulations or IRS guidance could adversely affect the U.S. federal tax treatment
of the notes, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Non-U.S. investors should note that persons
having withholding responsibility in respect of the notes may withhold on any coupon payment paid to a non-U.S. investor, generally at
a rate of 30%.&nbsp;&nbsp;To the extent that we have withholding responsibility in respect of the notes, we intend to so withhold.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">You should read carefully the discussion
under &ldquo;United States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying
product supplement and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement.&nbsp;&nbsp;You should also consult
your tax adviser regarding the U.S. federal tax consequences of an investment in the notes, as well as tax consequences arising under
the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #00D581; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>
</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">

<FONT STYLE="background-color: yellow">
</FONT></FONT><FONT STYLE="font-size: 10pt; color: white"><B>Hypothetical Examples </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Hypothetical terms only. Actual terms may vary.
See the cover page for actual offering terms.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below illustrate the hypothetical payment upon an issuer
call or at maturity for a $10.00 stated principal amount note with the following assumptions* (the actual terms of the notes are listed
on the cover page of this pricing supplement; amounts may have been rounded for ease of reference):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Stated Principal Amount: $10</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Term: Approximately 3.25 years, unless called earlier</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Initial Underlying Levels: For each Underlying, 100.00</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Contingent Coupon Rate: 11.00% per annum (or 2.75% per quarter)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Quarterly Contingent Coupon Payment: $0.275 per quarter per note</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Observation Periods / Observation Period End Dates: Quarterly, as set forth on page PS-6 of this pricing supplement</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Issuer Call: Quarterly</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Coupon Barriers: For each Underlying, 70.00 (which, with respect to each Underlying, is 70% of its hypothetical initial
underlying level)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Downside Thresholds: For each Underlying, 60.00 (which, with respect to each Underlying, is 60% of its hypothetical initial
underlying level)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>*<FONT STYLE="background-color: white">The examples below are based
on the above hypothetical values and do not reflect the actual initial underlying levels, coupon barriers or downside thresholds of the
underlyings. For the actual initial underlying level, coupon barrier and downside threshold of each underlying, see the cover page of
this pricing supplement. We have used these hypothetical values, rather than the actual values, to simplify the calculations and aid understanding
of how the securities work. However, you should understand that any actual payments on the securities will be calculated based on the
actual initial underlying level, coupon barrier and downside threshold of each underlying, and not on the hypothetical values indicated
above.&nbsp;&nbsp;</FONT></I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1 &mdash; The notes are called on the first coupon payment
date.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Lowest Closing Level During Applicable Observation Period</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-align: center"><FONT STYLE="font-size: 10pt">First Observation Period</FONT></TD>
    <TD STYLE="width: 21%; text-align: center"><FONT STYLE="font-size: 10pt">80.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="width: 21%; text-align: center"><FONT STYLE="font-size: 10pt">90.00 (<B>at or above</B> coupon barrier) </FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt">85.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="width: 19%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.275 (principal amount plus contingent coupon);
    notes are called</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$10.275 (2.75% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Since the notes are called by us in our sole discretion on the coupon
payment date related to the first observation period and the closing level of each underlying on each trading day during the first observation
period was greater than its coupon barrier, we will pay you a total of $10.275 per note (equal to the stated principal amount plus the
contingent coupon) on that coupon payment date, representing a total return of 2.75% on the notes over the approximately three months
the notes were outstanding before they were called by us in our sole discretion. You will not receive any further payments on the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2 &mdash; The notes are NOT called and the final underlying
level of the least performing underlying is above its downside threshold. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Lowest Closing Level During Applicable Observation Period and Final Underlying Level on the Final Valuation Date</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-align: center"><FONT STYLE="font-size: 10pt">First Observation Period</FONT></TD>
    <TD STYLE="width: 21%; text-align: center"><FONT STYLE="font-size: 10pt">85.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="width: 21%; text-align: center"><FONT STYLE="font-size: 10pt">75.00 (<B>at or above</B> coupon barrier) </FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt">110.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="width: 19%; text-align: center"><FONT STYLE="font-size: 10pt">$0.275 (contingent coupon); notes are not called </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Second through Twelfth Observation Periods</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Various (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Various (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Various (<B>all below</B> coupon barrier)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$0; notes are not called</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Final Observation Period</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">80.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">60.00 (<B>below</B> coupon barrier)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">85.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$0; notes are not callable</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-align: center"><FONT STYLE="font-size: 10pt">Final Valuation Date</FONT></TD>
    <TD STYLE="width: 21%; text-align: center"><FONT STYLE="font-size: 10pt">80.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="width: 21%; text-align: center"><FONT STYLE="font-size: 10pt">65.00 (<B>at or above</B> downside threshold)*</FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt">88.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="width: 19%; text-align: center"><FONT STYLE="font-size: 10pt">$10.00 (principal amount)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$10.275 (2.75% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Denotes least performing underlying</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Since the closing level of each underlying on each trading day during
the first observation period was greater than its coupon barrier and the notes are not called by us on the related coupon payment date,
we will pay you the applicable contingent coupon of $0.275 per note on the first coupon payment date.&nbsp;&nbsp;However, because the
closing level of at least one underlying was below its coupon barrier on at least one trading day during the second through twelfth observation
periods, you will not receive any contingent coupons on any of the related coupon payment dates.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Because the closing level of at least one underlying was below its coupon
barrier on at least one trading day during the final observation period, you will not receive any contingent coupon on the maturity date.
However, because the final underlying level of the least performing underlying is greater than its downside threshold, we will pay you
$10 per note (equal to the stated principal amount) on the maturity date.&nbsp;&nbsp;When added to the contingent coupon payment of $0.275
received in respect of the first observation period, you would have been paid a total of $10.275 per note, representing a total return
of 2.75% on the notes over the 3.25-year term of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3 &mdash; The notes are NOT called and the final underlying
level of the least performing underlying is below its downside threshold.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Lowest Closing Level During Applicable Observation Period and Final Underlying Level on the Final Valuation Date</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-align: center"><FONT STYLE="font-size: 10pt">First through Twelfth Observation Periods</FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">Various (<B>all below</B> coupon barrier)</FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">Various (<B>all below </B>coupon barrier)</FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">Various (<B>all below </B>coupon barrier)</FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt">$0; notes are not called</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Final Observation Period</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">75.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">90.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">30.00 (<B>below</B> coupon barrier)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$0; notes are not callable</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Final Valuation Date</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">75.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">90.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">30.00 (<B>below</B> downside threshold)*</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.00 &times; [1 + underlying return of the least
    performing underlying] =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.00 &times; [1 + -70.00%] =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.00 &times; 0.30 =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$3.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$3.00 (-70.00% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Denotes least performing underlying</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Since the closing level of at least one underlying was below its coupon
barrier on at least one trading day during each observation period, no contingent coupon is paid on any coupon payment date during the
term of the notes.&nbsp;&nbsp;On the final valuation date, the least performing underlying closes below its downside threshold. Therefore,
at maturity, investors are exposed to the downside performance of the least performing underlying and you will receive $3.00 per note,
which reflects the percentage decrease of the least performing underlying from the strike date to the final valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid">The
S&amp;P 500<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">The S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index
consists of the common stocks of 500 issuers selected to provide a performance benchmark for the large capitalization segment of the U.S.
equity markets. It is calculated and maintained by S&amp;P Dow Jones Indices LLC. The S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index is reported
by Bloomberg L.P. under the ticker symbol &ldquo;SPX.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&ldquo;Standard &amp; Poor&rsquo;s,&rdquo;
&ldquo;S&amp;P&rdquo; and &ldquo;S&amp;P 500<SUP>&reg;</SUP>&rdquo; are trademarks of Standard &amp; Poor&rsquo;s Financial Services LLC
and have been licensed for use by Citigroup Inc. and its affiliates. For more information, see &ldquo;Equity Index Descriptions&mdash;The
S&amp;P U.S. Indices&mdash;License Agreement&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">Please refer to the section
&ldquo;Equity Index Descriptions&mdash;The S&amp;P U.S. Indices&rdquo; in the accompanying underlying supplement for important disclosures
regarding the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>The graph below illustrates the performance of the S&amp;P 500<SUP>&reg;</SUP>
Index from January 2, 2015 to October 15, 2025.&nbsp;&nbsp;The closing level of the S&amp;P 500<SUP>&reg;</SUP> Index on October 15, 2025
was 6,671.06. We obtained the closing levels of the S&amp;P 500<SUP>&reg;</SUP> Index from Bloomberg, and we have not participated in
the preparation of or verified such information.&nbsp;&nbsp;The historical closing levels of the S&amp;P 500<SUP>&reg;</SUP> Index should
not be taken as an indication of future performance and no assurance can be given as to the final underlying level or any future closing
level of the S&amp;P 500<SUP>&reg;</SUP> Index. We cannot give you assurance that the performance of the S&amp;P 500<SUP>&reg;</SUP> Index
will result in a positive return on your initial investment and you could lose a significant portion or all of the stated principal amount
at maturity.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_009.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid">The
Nasdaq-100 Index<SUP>&reg;</SUP></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Nasdaq-100 Index<SUP>&reg;</SUP> is a modified market capitalization-weighted
index of stocks of the 100 largest non-financial companies listed on The Nasdaq Stock Market.&nbsp;&nbsp;All stocks included in the Nasdaq-100
Index<SUP>&reg;</SUP> are traded on a major U.S. exchange.&nbsp;&nbsp;The Nasdaq-100 Index<SUP>&reg; </SUP>was developed by The Nasdaq
Stock Market, Inc. and is calculated, maintained and published by The Nasdaq, Inc.&nbsp;&nbsp;The Nasdaq-100 Index<SUP>&reg;</SUP> is
reported by Bloomberg L.P. under the ticker symbol &ldquo;NDX.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&ldquo;Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; is a trademark of The
Nasdaq, Inc. and has been licensed for use by Citigroup Inc. and its affiliates.&nbsp;&nbsp;For more information, see &ldquo;Equity Index
Descriptions&mdash;The Nasdaq-100 Index<SUP>&reg;</SUP>&mdash;License Agreement&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;The
Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; in the accompanying underlying supplement for important disclosures regarding the Nasdaq-100 Index<SUP>&reg;</SUP>,
including information concerning its composition and calculation and certain risks that are associated with an investment linked to the
Nasdaq-100 Index<SUP>&reg;</SUP>.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>The graph below illustrates the performance of the Nasdaq-100
Index<SUP>&reg;</SUP> from January 2, 2015 to October 15, 2025.&nbsp;&nbsp;The closing level of the Nasdaq-100 Index<SUP>&reg;</SUP> on
October 15, 2025 was 24,745.36. We obtained the closing levels of the Nasdaq-100 Index<SUP>&reg;</SUP> from Bloomberg, and we have not
participated in the preparation of or verified such information.&nbsp;&nbsp;The historical closing levels of the Nasdaq-100 Index<SUP>&reg;</SUP>
should not be taken as an indication of future performance and no assurance can be given as to the final underlying level or any future
closing level of the Nasdaq-100 Index<SUP>&reg;</SUP>. We cannot give you assurance that the performance of the Nasdaq-100 Index<SUP>&reg;</SUP>
will result in a positive return on your initial investment and you could lose a significant portion or all of the stated principal amount
at maturity.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_010.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid">The
Russell 2000<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The Russell 2000<SUP>&reg;</SUP>
Index is designed to track the performance of the small capitalization segment of the U.S. equity market.&nbsp;&nbsp;All stocks included
in the Russell 2000<SUP>&reg;</SUP> Index are traded on a major U.S. exchange.&nbsp;&nbsp;It is calculated and maintained by FTSE Russell,
a subsidiary of London Stock Exchange Group.&nbsp;&nbsp;The Russell 2000<SUP>&reg;</SUP> Index is reported by Bloomberg L.P. under the
ticker symbol &ldquo;RTY.&rdquo;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">&ldquo;Russell 2000<SUP>&reg;</SUP>
Index&rdquo; is a trademark of FTSE Russell and has been licensed for use by Citigroup Inc. and its affiliates.&nbsp;&nbsp;For more information,
see &ldquo;Equity Index Descriptions&mdash;The Russell Indices&mdash;Disclaimers&rdquo; in the accompanying underlying supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Please refer to the section &ldquo;Equity
Index Descriptions&mdash;The Russell Indices&rdquo; in the accompanying underlying supplement for important disclosures regarding the
Russell 2000<SUP>&reg;</SUP> Index.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><I>The graph below illustrates
the performance of the Russell 2000<SUP>&reg;</SUP> Index from January 2, 2015 to October 15, 2025.&nbsp;&nbsp;The closing level of the
Russell 2000<SUP>&reg;</SUP> Index on October 15, 2025 was 2,519.754.&nbsp;&nbsp;We obtained the closing levels of the Russell 2000<SUP>&reg;</SUP>
Index from Bloomberg, and we have not participated in the preparation of or verified such information.&nbsp;&nbsp;Currently, whereas the
sponsor of the Russell 2000<SUP>&reg;</SUP> Index publishes the official closing level of the Russell 2000<SUP>&reg;</SUP> Index to six
decimal places, Bloomberg reports the closing level to three decimal places. As a result, the closing level of the Russell 2000<SUP>&reg;</SUP>
Index reported by Bloomberg may be lower or higher than the official closing level of the Russell 2000<SUP>&reg;</SUP> Index published
by the sponsor of the Russell 2000<SUP>&reg;</SUP> Index.&nbsp;&nbsp;The historical closing levels of the Russell 2000<SUP>&reg;</SUP>
Index should not be taken as an indication of future performance and no assurance can be given as to the final underlying level or any
future closing level of the Russell 2000<SUP>&reg;</SUP> Index. We cannot give you assurance that the performance of the Russell 2000<SUP>&reg;</SUP>
Index will result in a positive return on your initial investment and you could lose a significant portion or all of the stated principal
amount at maturity.</I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_011.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; font-size: 10pt; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Correlation of the Underlyings</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graph sets forth the historical performances of the S&amp;P
500<SUP>&reg;</SUP> Index, the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index from January 2, 2015 through
October 15, 2025, based on the daily closing levels of the underlyings.&nbsp;&nbsp;For comparison purposes, each underlying has been normalized
to have a closing level of 100.00 on January 2, 2015 by dividing the closing level of that underlying on each day by the closing level
of that underlying on January 2, 2015 and multiplying by 100.00.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We obtained the closing levels used to determine the normalized closing
levels set forth below from Bloomberg, without independent verification. Historical performance of the underlyings should not be taken
as an indication of future performance. Future performance of the underlyings may differ significantly from historical performance, and
no assurance can be given as to the closing levels of the underlyings during the term of the notes, including on any trading day during
an observation period.&nbsp;&nbsp;Moreover, any historical correlation between the underlyings is not indicative of the degree of correlation
between the underlyings, if any, over the term of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_012.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE AND CORRELATION BETWEEN THE
UNDERLYINGS IS NOT INDICATIVE OF FUTURE PERFORMANCE OR CORRELATION</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Correlation is a measure of the extent to which two underlyings tend
to increase or decrease at similar times and by similar magnitudes over a given time period.&nbsp;&nbsp;The closer the relationship of
the returns of a pair of underlyings over a given period, the more correlated those underlyings are.&nbsp;&nbsp;Conversely, the less closely
related the returns of a pair of underlyings, the less correlated those underlyings are.&nbsp;&nbsp;Two underlyings may also be inversely
correlated, which means that they tend to move in opposite directions from one another.&nbsp;&nbsp;The graph above illustrates the historical
performance of each underlying relative to the other over the time period shown and provides an indication of how close the performance
of each underlying has historically been to the other underlyings.&nbsp;&nbsp;However, the graph does not provide a precise measure of
correlation and there may be relevant aspects of the historical correlation between the underlyings that cannot be discerned from the
graph.&nbsp;&nbsp;Furthermore, regardless of the degree of correlation between the underlyings in the past, past correlation is not indicative
of future correlation, and it is possible that the underlyings will exhibit significantly lower correlation in the future than they did
in the past.&nbsp;&nbsp;We cannot predict the relationship between the underlyings over the term of the notes. For additional information,
see &ldquo;Summary Risk Factors&mdash;You will be subject to risks relating to the relationship between the underlyings.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The lower (or more negative) the correlation between the underlyings,
the less likely it is that the underlyings will move in the same direction at the same time and, therefore, the greater the potential
for one of the underlyings to close below its coupon barrier or downside threshold on any trading day during an observation period or
the final valuation date, respectively.&nbsp;&nbsp;This is because the less correlated the underlyings are, the greater the likelihood
that at least one of the underlyings will decrease in value. However, even if the underlyings have a higher correlation, one or more of
the underlyings might close below its coupon barrier or downside threshold on any trading day during an observation period or the final
valuation date, respectively, as all of the underlyings may decrease in value together.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the notes are set, in part, based on expectations about
the correlation between the underlyings as of the strike date.&nbsp;&nbsp;If expectations about the correlation between the underlyings
change over the term of the notes, the value of the notes may be adversely affected, and if the actual correlation between the underlyings
proves to be lower than initially expected, the notes may prove to be riskier than expected on the strike date.&nbsp;&nbsp;The correlation
referenced in setting the terms of the notes is calculated using CGMI&rsquo;s proprietary derivative-pricing model and is not derived
from the returns of the underlyings over the period set forth in the graph above.&nbsp;&nbsp;In addition, factors and inputs other than
correlation impact how the terms of the notes are set and the performance of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt; color: white"><B>United States Federal Tax Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal tax consequences of an investment in the notes.&nbsp;&nbsp;In connection with any information reporting
requirements we may have in respect of the notes under applicable law, we intend (in the absence of an administrative determination or
judicial ruling to the contrary) to treat the notes for U.S. federal income tax purposes as prepaid forward contracts with associated
coupon payments that will be treated as gross income to you at the time received or accrued in accordance with your regular method of
tax accounting.&nbsp;&nbsp;In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, which is based on current market conditions,
this treatment of the notes is reasonable under current law; however, our counsel has advised us that it is unable to conclude affirmatively
that this treatment is more likely than not to be upheld, and that alternative treatments are possible.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the notes is respected and subject to the
discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Any coupon payments on the notes should be taxable as ordinary income to you at the time received or accrued in accordance with your
regular method of accounting for U.S. federal income tax purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Upon a sale or exchange of a note (including retirement at maturity), you should recognize capital gain or loss equal to the difference
between the amount realized and your tax basis in the note.&nbsp;&nbsp;For this purpose, the amount realized does not include any coupon
paid on retirement and may not include sale proceeds attributable to an accrued coupon, which may be treated as a coupon payment.&nbsp;&nbsp;Such
gain or loss should be long-term capital gain or loss if you held the note for more than one year.&nbsp;&nbsp;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the notes. An alternative characterization of the notes could materially and adversely affect the tax consequences of ownership and
disposition of the notes, including the timing and character of income recognized. In addition, the U.S. Treasury Department and the IRS
have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo; and
similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance. Furthermore,
members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury regulations
or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment
in the notes, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative tax treatments of the
notes and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Withholding Tax on Non-U.S. Holders. </B>Because significant aspects
of the tax treatment of the notes are uncertain, persons having withholding responsibility in respect of the notes may withhold on any
coupon payment paid to Non-U.S. Holders (as defined in the accompanying product supplement), generally at a rate of 30%. To the extent
that we have (or an affiliate of ours has) withholding responsibility in respect of the notes, we intend to so withhold.&nbsp;&nbsp;In
order to claim an exemption from, or a reduction in, the 30% withholding, you may need to comply with certification requirements to establish
that you are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult
your tax adviser regarding the tax treatment of the notes, including the possibility of obtaining a refund of any amounts withheld and
the certification requirement described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities.&nbsp;&nbsp;Section 871(m) generally applies to instruments that substantially replicate the economic
performance of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations.&nbsp;&nbsp;However,
the regulations, as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo;
of one.&nbsp;&nbsp;Based on the terms of the notes and representations provided by us, our counsel is of the opinion that the notes should
not be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with respect to any U.S. Underlying
Equity and, therefore, should not be subject to withholding tax under Section 871(m).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the notes are not subject to Section 871(m) is
not binding on the IRS, and the IRS may disagree with this treatment.&nbsp;&nbsp;Moreover, Section 871(m) is complex and its application
may depend on your particular circumstances, including your other transactions.&nbsp;&nbsp;You should consult your tax adviser regarding
the potential application of Section 871(m) to the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We will not be required to pay any additional amounts with respect to
amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement.&nbsp;&nbsp;The preceding discussion, when read in combination with that
section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning
and disposing of the notes.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the notes and any tax consequences arising under the laws of any
state, local or non-U.S. taxing jurisdiction.&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt; color: white"><B>Supplemental Plan of Distribution</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
lead agent for the sale of the notes, will receive an underwriting discount of $0.10 for any note sold in this offering.&nbsp;&nbsp;UBS,
as agent for sales of the notes, has agreed to purchase from CGMI, and CGMI has agreed to sell to UBS, all of the notes sold in this offering
for $9.90 per note.&nbsp;&nbsp;UBS proposes to offer the notes to the public at a price of $10.00 per note.&nbsp;&nbsp;UBS will receive
an underwriting discount of $0.10 for each note it sells to the public.&nbsp;&nbsp;The underwriting discount will be received by UBS and
its financial advisors collectively. If all of the notes are not sold at the initial offering price, CGMI may change the public offering
price and other selling terms.&nbsp;&nbsp;For the avoidance of doubt, the underwriting discount will not be rebated if the notes are called
by the issuer prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; color: white; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid"><B>Valuation
of the Notes</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the notes set forth on the cover
page of this pricing supplement based on proprietary pricing models.&nbsp;&nbsp;CGMI&rsquo;s proprietary pricing models generated an estimated
value for the notes by estimating the value of a hypothetical package of financial instruments that would replicate the payout on the
notes, which consists of a fixed-income bond (the &ldquo;<B>bond component</B>&rdquo;) and one or more derivative instruments underlying
the economic terms of the notes (the &ldquo;<B>derivative component</B>&rdquo;).&nbsp;&nbsp;CGMI calculated the estimated value of the
bond component using a discount rate based on our internal funding rate.&nbsp;&nbsp;CGMI calculated the estimated value of the derivative
component based on a proprietary derivative-pricing model, which generated a theoretical price for the instruments that constitute the
derivative component based on various inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the
notes prior to maturity will fluctuate based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or
Citigroup Inc.&rsquo;s creditworthiness.&nbsp;&nbsp;These inputs may be market-observable or may be based on assumptions made by CGMI
in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">During a temporary adjustment period immediately following issuance
of the notes, the price, if any, at which CGMI would be willing to buy the notes from investors, and the value that will be indicated
for the notes on any account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one or more financial
information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.&nbsp;&nbsp;This
temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the term
of the notes.&nbsp;&nbsp;The amount of this temporary upward adjustment will decline to zero over the temporary adjustment period.&nbsp;&nbsp;CGMI
currently expects that the temporary adjustment period will be approximately four months, but the actual length of the temporary adjustment
period may be shortened due to various factors, such as the volume of secondary market purchases of the notes and other factors that cannot
be predicted.&nbsp;&nbsp;However, CGMI is not obligated to buy the notes from investors at any time.&nbsp;&nbsp;See &ldquo;Summary Risk
Factors&mdash;The notes will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; color: white; border-top: #788D41 3pt solid; border-bottom: #788D41 3pt solid"><B>Validity
of the Notes</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Davis Polk &amp; Wardwell LLP, as special products
counsel to Citigroup Global Markets Holdings Inc., when the notes offered by this pricing supplement have been executed and issued by
Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such notes and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets Holdings Inc.
and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability
(including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses
no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed
above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York, except that
such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In giving this opinion, Davis Polk &amp; Wardwell LLP has assumed the
legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup Global Markets
Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc.&nbsp;&nbsp;In addition,
this opinion is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024, which has
been filed as an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has been duly
authorized, executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the terms of
the notes nor the issuance and delivery of the notes and the related guarantee, nor the compliance by Citigroup Global Markets Holdings
Inc. and Citigroup Inc. with the terms of the notes and the related guarantee respectively, will result in a violation of any provision
of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable, or any restriction
imposed by any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Alexia Breuvart, Secretary and General Counsel of
Citigroup Global Markets Holdings Inc., (i) the terms of the notes offered by this pricing supplement have been duly established under
the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings Inc. has duly authorized
the issuance and sale of such notes and such authorization has not been modified or rescinded; (ii) Citigroup Global Markets Holdings
Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery of such indenture and of the notes offered
by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance by Citigroup Global Markets Holdings Inc. of
its obligations thereunder, are within its corporate powers and do not</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">contravene its certificate of incorporation or bylaws or other constitutive
documents. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Alexia Breuvart, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Global Markets Holdings Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed
above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures
(other than those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all documents submitted to her or such persons
as originals, the conformity to original documents of all documents submitted to her or such persons as certified or photostatic copies
and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Karen Wang, Senior Vice President &ndash; Corporate
Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of Citigroup Inc. has
duly authorized the guarantee of such notes by Citigroup Inc. and such authorization has not been modified or rescinded; (ii) Citigroup
Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup Inc. of its obligations
thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents.&nbsp;&nbsp;This
opinion is given as of the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Karen Wang, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed above. In such examination,
she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other than those of officers
of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the conformity to original documents
of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>&copy;</SUP> 2025 Citigroup Global Markets Inc.&nbsp;&nbsp;All
rights reserved.&nbsp;&nbsp;Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are
used and registered throughout the world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->
























<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  1  X# 2(  A$! Q$!_\0
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3L?HB[0,@#C)Y)S0!O4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  1  X# 2(  A$! Q$!_\0
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3L?HB[0,@#C)Y)S0!O4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  1  X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#U_P =:C=Z
M3X%UO4+&8PW5O:/)%( #M8#@X/%;%A(\NG6TDAW.\2,Q]20*X_XJ:)XBUSP;
M=6_AV],<I1EGLS&C"ZC(Y4%AE6],$>GN-KP=I^M:;X9M+?Q!J(OM2"@R,L:(
3L?HB[0,@#C)Y)S0!O4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_009.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_009.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M=^_]]^"'+_[XY)=O_OGHIZ_^^NQ#+] \!AR0,1$( %!$1L>,@8PWM;BDNRG
M0 4]:I&@=BPH%!$:DH3^L0U77"A#&_I'AW*!C&)8\((8S* &-\C!#GKP@R ,
MH0A'2,(2FO"$*$RA"E?(PA:Z\(4PC*$,9WC!69 !!#DK R\ P0C"640;[OD'
M(/]R1Q!AX())_Z@'*:YA"H&( CJB,$\QO*&>?] C%P-AA:Y,Q\4N)HP15DN
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M@.,76_P'+] )X&I;#!^?AAD+*F"U22RC#3 3IFKX9C4W-,07LHT(>6DQCW\
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M 1/@"P*1-U)5J?AA#6%0  70 F.D$*Z<,8_Z+N,<'GJW#X(@"HYP#7\T"('
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M%Q, R8F7 0,,JS@0!CA0M4H1[44@T8.?3@:UOT6NJT2QH92$P!J;I)&%"#*
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MA1J(@11  13POH?(!VOP%&.0AG^8AVVH,G'PAF-@"'!PAIX )D 9!F^(LW[
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M A'PA!\9!W@(!E)@,3(@B U@!$=PA-(XSH$ T(MP!+W@@J*446L*+C[0N'\
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M*+WX!3GHZQ"@P^7([H$H7>ZF;.DD"G4 :8; SMG^!^S<Z>]6K7@0 HI."2A
MW'S(@8%PD6T0(B(@@E48"E>0 1,@@B-X 4L$4H*0 ;YPCOT&@-#U;X-.BFX
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M#5+$4AFY<%M%8-&,FMQA+5S0R#Y(X)Q<!+.=[GRG18:I$GLD+"@E>@D;!!(
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M R>P S3DP3Z80QVX^RI$G"+( CA@0R-8!#)L@CF4PB&$DAZT"CR,P3V 0RQ
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M!41!%73!#JR2,2:!##2A&,$-%QH!'\J!&1V"'!0!&J6Q$ AAK#C*"UYR%JI
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M8H%-"<$.4J%7!;58<$'A/B(8CG44N*#8" (;N(H5EFV4LJ 4>A45HBU><>$
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MDMEFG0433VCWO&))%Z+8(R>9G!ABT4#NL,$?07HPZ5>GGO;D2".>3/*))*F
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M%0!0#7;0 0L<F  X+M"#?WP" #_@@0&@(.$4JWC%+(;M=HE "T0 0 ?I  (
MG/$#!IPC 2'XQRP H =FC,%K+2ZRD8^,9,LZP[C&#8$O_F&( ,2@!QI(QA
M\(5QO&$%))@ .I,,YC"+><Q^D0<QSAR-!?U#&D\-!CO $8RF1N,7BR.SG>^,
DYSSK><]\[K.?_PSH0 MZT(0NM*$/C>A$*WK1C&X$-'8# @ [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_010.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MZNNOP 8KK*GT- ," ( 2J,LL\HR3#BS;W),*/^* 8\Z.O#P3#B[Q5*,+.*L
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M#"0*HN/XPDS<@V03.Y/;"+3+9^?@4HTP5"8B4#BDV$)./_CGK__^_/?O__\
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M <@R(&WL,H<LQQO!#X72#)*Y95YCF6*#F69#$)O)-F[CF8R\G^EPL99$!^A
MD"!K$+B@D);0 C=P!Q=1R 2+R.":$>#0#8N #NB@#*B@"L,P;;XY:,%I:,29
M:,;):,GYQ+<<E,MG2680"/PR#08Q"_SR2ODPF12!S*5\M!GA#:Q0".(0#@C6
M"_*WGK#6GK,&G_+Y#[=6G[J&G\P3SJ'I#,^PJ9;T M4) &Q<$'&&+!E[$<I
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MUFH2W0L C13?-QRY0),,CB.%:%6%:W6%;I6%<35776A76%Z#[Q /\:"GR.(
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MB%(XJ%OXCGT0A62(J'0PI7^XH$?@H2QBS_9TS_>$S_B43Q/:AEB())5H@A^
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M#E29RU;7_&9/AM$&+D#& )^(R3.30JP7A <3X'PG9;)YK*_!LYXR^<4&PC,
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M(8YQRN.>X1*WN,9U#S):00E.=$-BRU"&,?"P@/"PHAB:,(,7L."'7B4E +U
M1C'BH0SG $,,26' 10&P!N<>M[WN?2]\X]L=^,CG*>M(S3],D99_%*AD"&HF
M@QSTCUF03$*IJM"%\I&A?VRH0T1Z,(0C+.$/Y:/"\W '.O(Q#QB5(QW!X$!2
M=/_ C77 8Q]TD-<!0A&+ZB7E#>(HAXG*<6)Y.0+&$[XQCG.LXQWSR$AF?4HZ
M0I&-?>SB'%G:4I>^%*8QE>E,:5I3F]X4ISG5R2!X2JV>P@$/>*B#&\> !\6
M8@\LA.<0_R"'9N4U  TT@,4 *%U.>$& \"S 3EB^<TP^%Q5ZX.)_LMQ4ISX5
MJE&=V52H4M4_6.4J6,DJHCO%,V+ H0,!"  3,-"  #01E$1X0%Y+J(<B]#D
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MG<,6N/\9!G ""?! "LB+$LP? "Q!,7##.2@#!'V##;!8 ^3!/@ #OU5>>(0
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M.=R"/QP9EW@)F(@)F9@)FJ@)F[@)G,@)G=C9E8'3-:@ A.IC4HB DRR*/'C
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M.$/]_@,V7 (03/]"(HA!%"1!(:A & QIY@"  G1+3)0;BSE!;V)"'YP !'Q
M)EGE$;3!,6!#J@$  \1!"T!&%<1!'*P V>P!/H04"[]Q"__J4"BDL'*O+YR
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M!+NI@YZ%*58G+4FPPA? .(-B_[$()6@C&5^8 T@(H@QM!'L4763(*&AZ[G]
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M"86@"&@6>[<H%-Z&"WZ@!V^86M- AB11"J'4-H9@"=EP#L^ !A*C*Y#P"X
M!H)P105A#ZWP@D Q!E9%$,/ !MIP#M'@"(UP@>U@"=/V!SH3%.%@#0XE%*D
M"06!#H<@"=]P#L>0!Z'09^[@"*T0"&!@";#X1Z"@C4!Q!^%$$-30!L%P#L4P
M")%P303A#^4H"7Y0"D)1#[003:"B3Z=2"Y0 #.?0#)20"WVF#H? "XAP!Y+0
M70Q!#\-@@T A":/ $-8@!JYP#OB0"WAP1>10"=60"7KP*4&A#[T@A$!A!Y.C
M#K!08^> #(UP".@7"Z3@"WD0_PD961#O0 P8%12<H%,$ 0Z-  C;< [)P :
M11#LH G:H EY\ @76!#]L JA2!)\P&VI@ ;3< [7H F%4&?2( C)D =D()-!
M$0^B0&PN5Y$$(0[.8@SGX QDT#P3,0^<, R3< >&\)#IA0KC!11BP)G]10WG
MP W[XI:X&'OZ$ _RL SRX HK"0[%4 II$ 2E0(?^E B,,%[*8& %X0YJX$?J
ML _G( W*4 PK,Q'LT R!X 9TH H+EA:2L GLHPYUT%V2$ P%D0_Q< _-P W*
M\!#^@P^F  9+D O<QA#N< B1L(;_L TY]A5J@#OR\(W'$ ^_T&?K  V#, =S
ML I62?\0YI )G( [85"4FM!8)1$/[? -Q@ -!ED0^I ,FP $!-=W#!$+8. Q
M_R /;# 1;4"'[8 /\< ,YP **E0.UX (?' &M)!O#:$)FJ!8?D!]A3!$_^ .
MJ8D,V9 -9GECSF (7Y 'Q-!:!7$,8' *=M(/C\409+")YH /^& -^P *]08/
MW' *== 'N'"*!4$/G) )+2<,F,!E;=!.^" /V0 -W'"=0?4,CJ $?C ,L3,1
MR! )A] N[R &<94&]'(4\5 /QU ,R^"%&:,+G( $DP ,VE,0Y; )G^!P_X -
M)E5;:D! Z' .^V ,S; -8T<0XW ,B2 ';. *XL<0TL (B6#_&>D@!EUT!XEH
MFKC("HU@"9K@%KX0@?= !V)0#:00+D(A#M! 2L>PFP5!!S/F#H;0")50"9EP
M";W0+M2@!'D0#9C J<[1#'&E#K[)$)E0>>W0"$MA"95@""_)#W4@!L*@"YDP
M%.J #-UE#+3'$&HP4NJ@",FZK%QI&<?0!VE@#)RP"D,Q#\JP2G40@?_0K 7A
M#]^J"99@"9N@E?\0"DG "?O !O[)$-FP8.= I@S1!AOW#X0@JYH0H+@P8\@
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M"ID0"9+ "^YKP8? ".:I*+9P9&PL*>]@"I\0"9[PN$"!#)P ":N4#]I0"&D
M"/Y"*<%@"<M,"UE<$*#0"2L+D<+0"930RY0R#S45"9I@N20QFH)0;^"0#(F
M!H9PC491#960QZQ0;UI\B^'@"EL:1*X:>_70"KM;$-# F;'W#0X*%/KPDK''
M#Z,PC?2%/+=X#14<%-/0HI!F#Z, D!,A#0<->]+0R$&Q#$49>^S0"G)*$L60
MH;<8#ZDW%"/ZJL] T4/2:Z^Z#[H@P<;E_[H.+=533=55;=57C=59K=5;S=5=
M[=5?#=9A+=9C3=9E;=9GC=9IK=9KS=9M[=9O#==Q+==S3==U[=;J@ =ND 19
M 'U @0^0X,MV+=B#3=B%;=B'O4CJ0 $ T     !1\#/M8#[J4 4 X KQ,0_R
MX,Z(S=F=[=F?#=IBK0X!D +OX ]!  "TP Y4H ,;< ;>\   8 '.  HO$  G
MP*.AK=N[S=N][=N5H@X?, ($(0P P G%P BSL ( 8 UE  #.T \<0 /5$  B
MT-"_C=W9K=W;7=CJ(  [0!"S  "0H Z>8 ,X  #0T 8 8 _1   >T ,&$  %
MR]WU;=_WC=]CK98.!I !M3 (.S  T2 * * (?P  QF ' ! -_= !+8 -C7 '
M29??$T[A%6[AMZ@.&^#8 $ !E? /P# !&< $ ' *B#  ,W .A%  -^ !C.#,
M%P[C,2[C,UYWWD ,&X</H$ .SB!+R] *"\$-O/#%,T[D16[D1X[D2:[D2\[D
<3>[D3P[E42[E4T[E56[E5X[E6:[E6Q[6 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_011.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_011.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MHP04"$(8O >%?P"C< CX1R6 Z3U+$.01A8N#0,I1 :B6H7"7H! Z#+7)PEG
M%Q< 0 R@44#OR:$4$WT((KP'AH((M21$+:IAP!$%[W6O<&OX!S4*)X-_S*&$
M4JB>0 Z;152DPA2K#"<F"G>(K39('S.@@068F@Y^UB .5(4@1'BQ"S!X;XA!
MK2AY+JI7T;PCG26<PCX84;@'_Y3!!G_TJ#LR843[$> !A9/"(0J'A%C00@8C
M>(/^_&,,^SF $. X1V3_.('U.20?3_2>&^RJ6O:PMK6A6<0?9RK-\1;NA_]@
M@GD!,(I=V \#A:/"<L.CC"E, 0[-,@@I[&< ?ORC'=,M80;VX1!8U$ #%!2"
M_NY*DKR"=S"16*^$ 4 ':RSAFN:M!2S^6(7W)$.=O/J',)9@!4VH@;_0^%R
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M\R@(/W1P@#+P*0^%L\+\$***PJ5 'GD$Y$$8/!('MSPEKVB ]V:0C?("H 5
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M$#%_ * *!R$.[68_XJ809"<29D> (]$.CN0])O .[P .3L  'Z , G$('+
MBU 0PU X)3 /!#  .H T!R$JMF )F3 -2P  &K!3 Y$*A5,'OB$%A4,+ J$,
M:[ &F200/K!>B@41\P0 +# &7"!%XL &6I!&]B,OTN%Y"P)Z/M@7XQ!TWA,#
M [$/Y! /@?]G#NJ #X5'$/J0!G,@".&@#/ZP=0QQ< Y@"P6!50"0:KLA#IV
M=![U#Y]4 ]8E#B5 00907HD@$:- 0='C#7\D _\F@,]7B)&A":&%6BBA!X6C
M". 0>-*P S478K4Q#B55."X@-=XS9_\@#R   !'05@K@AP# >1$1#,Y53?^0
M"M=G/_7$$#L8$CWHBQ_Q4-[SA"G1:P!   =P (L #?STCK7Q#D.  ,!5. 1@
M"/\@!MZS;?_ #25% XCX '$( ""0;!%Q@][3?>L 6Q0D"*,AB!)"B.SX$FQ
M0:R6$IE 02^0#:]6.-2 &NO@"XO0!KR$#K/P1PY0"J]8.!\0-<W_L$I4T($
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M^: /JK +M? .]I *K) (ES*BI1L8Q8"(A7.R*[$.OA<! ?8"1KD'"K$/A.8
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M_DQ!7_ /Z=!;<FT0FBF%B!'B(Y[9.6WB(=&> ' $!=>0]C/7Y^ $A2H,!PL
M#> )_T .V.T]"; +XA"<*]#=E@GDWHWC]G,% G'+]K,!M4P0N%@X1M?;]J,!
M$'R<P<TC\BWE#;%$ " %DO\!!24TU^# DPIP#,50CCHP)^KU1[FPKJGW?T$3
MX0;1#_;L/4L@$(0  T?0 ][SN@1Q@0"@!5II&)6=TB2NV83^$8:>!9*!!HN.
M;GIN#^1P>85S <NP#CQ@U]F& >>(#F-$ 7@]$#&VKSLE#BONRMMU)]M,BH=!
M0H6S!Z  L0%:XK.^$=L' "E@IX9Q>"XN$$AG!?\@"J$E"NP0EFHVC]N<!MXW
M[ :0!4N0!3NP!#%D"X3F/8!P$+5IK@/A#ED ZHDQIX6S;A5QUAX!Q%(>G'W0
M"Q]]&#.:Y>A>.%8.#10$#_A@/U2 80K ?TWP1F/P1S,@#+YN;7"0N@;!46H5
MDNK_,%TN\.>#T>(7%.M1_NT<D4L- (.0,<I9OCPRR 7_$ X'[SW2 $+>DP;F
M3GHNM@=FYCT40,$)(8H D 3]( [)L/)>0.Z!40U_E?-0'M\\'Q+\4%(?$-:,
M<0J!/0 [  ;W^0#\_ ^&( #D#0'T"@!\D M8J0%3*1!/;UX+\-,$\0YD">8!
MT J-5#@*8(:(D0XU2?;PG4AG#Q+3 %]W/1G%$.]_I %0/ [>H-P41-1LZL %
MH0L3)@"!A!#H\*8 < %V4*X ( :(2QCK\'"4'Q'[02^C\/O S^UX->@PP@_:
M4/'&00VT0P"\"QGQL/)_%  S+5,4%*<2#  ?T-T" 8X2_P8!Q<>"!_='-!#H
M*L%O5J_S"$$+*T #-) #.7 #-T!W44+\*L(,+H !,B#_QU$/L"4'R'\8 $&/
M @  (5X01 @@0+M_#?\)29C0T[]B$7DY_"<JXD8 !<9A!-FP&@>.8T*>1)E2
MY4J6<@@F8JG2%+F5]JKA8Z<O7CQ]X&+^!/JOE+"@18T>19I4Z=*8XI8@+,14
MZE2FPA :HIIUI4""BN)L['#1X:2--X3I^]<+88,D^S""2DBCPL8']5ABX5A&
MZUZ,S) 5@Z=TYD];<A3Q:L8WYE#%C1T_UDH3HYB$"TX0@YR9J3\+!"=ISJIO
MX -?BSC&PFAKXRJ'FQ B2 =R&/\#A*LX12RSS!W+)QS-@ 8N4_+*7E2V]!%D
MA%WPAHR9/X>^-YP<'BD:.0(&;!Z-C5FB_\R6/9QC=IT!=/J.=!C!%_\H;82R
M#F.TC:<<JE-%T$7(=2(0EB&E!H*T$"6PF*C@Z)/TF!N,)3XND0:/<X[8YCGG
M%L0PPY7$*6&C)+;@J!8-3^J!(&.^^>()/O8JCZ!,1OQ)F!) B.*?1C;"!"2K
M(OH&HWYB,"&)D[[)PX,*2OG'&!10^ PH:^ X(")"8(2LP95J\0*.+.!H0AX+
MB:(RS RAF8LC@DA"Z#<JR<&EE8,<  $A#I;+JAH( .A $C%9*H<F2Q!:8(89
M -%Q(S#_,5IG/)2NX8>I0B)J94_%K%RIE26Z.(,9Z"Z4M%/0@O'!3((*@.43
MA&Z(;<1V6B#(@(TDJ$:K9#H X A/6?J3H#I0VK'5,?)YCHR(T+N5*DI3DD><
M!3DMMEFMUEE#5()&V,T0VCJ(=<0PI$5AKU0(>L-9E'(%0,^3NHE('>A,0^B!
M0,1EZEB4(.GA$6QVV_10>/=="L2$ M@@H1D^^N<&  3 3$-V)I#V!W^FVD>4
M<_ @"!)^,3*5(%10H@6A%^9PZSE3-$"H$Y\N/DK>DXC9! HLN$CDG"]1IKDH
M9Q*(: 4D"!+ACE0<8A4#=3/D9@]I ?@@,:DP,6""!PA2A>9U__0@J *93Y($
MH5O2,X$@!Z2IV2B547)&#1IRX&;FL-=.Z9@ -GH""H(BQ8A5"G+)$)\+'$"H
M"28V,F!CIO@A("*\44:'"X+42(D>(D2 !-_H<B HBI/9CFELD B10@LX!.%&
M<N"8Q9SM>K1 Z (5"+I%GFYT80BC$ @:0JI]AD[JCH26:*B3@1)B1*I=-G*E
M9G6D:64XE!1-3Q&"O"L]<^534D63;*,C/7I)TZ"!AL/_@>?AR1**@A]D<+$+
MI8, <&,I:F@  0ZEO.D0H7 ;NB B2Z2*1H"(<-&>I(IQ@BV$ 1T!% Y0F $-
M=LA';0B45#IF0! 0J.L3+_A!*!S2#_\,("0%RH@)(FBE@V$ !7<.201!=( 4
M?&2!5@CI0[:RP;<+0 0 E5!*^KCAOX2P H)B$MT/0Z(YC/@##2#PPR46\8X'
M"A%&_E@=021 CVT@I 7NT,8W"&$>$F@J)O0(& !F\(UO0$,EMLA""U3 !G7
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M=][SGP=]Z$4_>M*7WO2G1WWJ/7\-0CS-3#%0 1:R<0U\),.5#K#!$D2A_W4
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M41"M:MPL=3@'=7"@5(@",]B"F1H!O-D' H/'?T@'??A!<HL'=4A%Q7 >@D"
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M4@UIX(;P+P#( ;F=8.44WG_ N'^HA_2Q4HR !<4)5(0@E.]XA2? 1 !0@"%
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MYN@',Y%SRU<)_W"0KLK'?2<*PZD8O(9 A.W5!EXPA8%K!8-3.(ZL!(8[!5B
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MR-*=*R;UHLTPU/QCET&[6)0UW88&3$HCLL3B3B[&C?,+-K045 C+_PR",C+
MY +-/_/@4I XI!#S#N656WXYYIEKOCGGG7O^.>BABSXZZ:6;?CKJJ:N^.NNM
MN_XZ[+&##LK+I,G#,C+?^&+-1;A, ]H_C!#T#R A41,,*LPTWDI!U2Q"BC36
M2#\]]=5;?SWVV6N_/??=>_\]^.&+/S[YY9M_/OKIJ[\^^^V[_S[WQ) RO/]I
M_LR\S2K-+/-/.[G@L]$Z9N&0?[#":LCHAC>R\0]N"*X@<JL;! <5L&3H@AJ\
MH$<X2 $,64!#'*@PQ2W<QH]S/.,7P<!%.>21"F>$(AY7BR ,[72P;-CB:/^
M2S$*<@Y?$&,Y;0F;*_A1D&N\@G$OC"$2V^0QT>0LB4X\T1)#T\0G4E%$4=S,
M%*NHQ0Q=43-9W"(8&=3%S'PQC&9\4^U\Y*TSLG%4:3S2&MLHQQB-$3-EG",>
MP5/'R]PQCWZ<T1NA%,<_$I)#>[1,'PNI2-(<LC*)7"0D-=-(RCPRDI:LS"0G
M4\E+<E(QF93,)CLI2K!\<C&A'"4J#5)*Q9PRE:C_7&5B6NE*4<(2,;*<)2=K
M*99;XM*2N@P++WL)R5^")9C"5"0Q%6+,8Q(RF0E9)C/]Z$R$0#.:>)PFS@9I
MS6W^*9!9TB8WPTDM;X8)G.(\)V*P>41TLG,QZBQ(-=NIQ7?^(Y[RI"(][7E/
M)^;3G/ML9S__*= 4D3--_ARH. .*T($J=*'_;*A#[PG1B *TH'$Z*$696<=I
M($(5-OS'/F:!"%^L QVT0 0K;@9/C&94F&.$1RG(40Q2S.P?SJ!&.5)QC6.\
M(ARK2,8Z6WK.,4[#%@49Q#X*T@K$&0,4)IE'+0RBBV8(M9VG& =XB(&*@BAB
M>)7XRC=. 0OEW2,4!<$'_R8H@8NULI6MLBA$6^.*"T(D0JYM300A[,K64 Q"
MKVM%1"O\BHM!J,*O;Q4L+N#J5[P*5A5]]6LK$"%81(1"L'05K&+]6@A9^-6Q
M@@V%9/U*6<$.HJZ+S:MF.:O9P.H5M()M16;M2EC+HE:OB7BL7@O!6KV.5J^1
M%>QA_7K9Q>+6KIN=;&7].EN]!E>S@F5L9XLK5\"2MK#"140CZ(>=9FSD'QTI
M2"U"L@QKE.0DNBB(.9)1#'G4@QWN94<[VL&.><!B'/EXKWOORPY@+(.]^&5'
M/MI+#&?X][_PJ$<W0#$.^>*W'?!@!R^J\>#_UN/!H%AO>_&;CW;@ Q7V_:^#
MV?_ACU'PX[_L@(=\O2$*$Y_XOM&@!8OS\6!EP(+%+<Z%-@J,7WC (Q;]S?![
MZR$/?NQ"'A/&KY#;L0M^'-C$\.A&+,9QY/>V0Q['H(4\&+SC<;A"&5-^;S[&
M<8IH-/F_^9 ',I)1YB##8QRH\(>6V3R.5>!#OPV6AS)<L>;_/F,7-G:O*Z3Q
M9W8$PQF#)@8H6-R.<<B#%=P ,)#9(61YK$(;D-;P.)ZA"TG;.;_CT$<I.,UB
M47Q#RC9&1C 6;&-6]./+^.W%,W3\WU=,(\[XQ<<H FSC$4O:QBKN='[;.PQ?
M9!G)^NW%-;Y<#_VZ0ANNUN\IK%&X[]B#%<\P!DG+ 8[_HMZ#%/"@ARY0LHT!
MVN,>^0@+/>(ACH6@%Q_U2$A-T7$-(28DJ?_ !ST4$I)QS.,K"0E).>YA-82(
MPR'I7@Y"[ T6CX@%' @'"X#$ H^;]8,="B$'ROAQ((3XXQ_FB,>T#])Q<<3C
MC>? AXA5BA!]Z$/$"K%'//S!CY ;Y./\&"%8Z(&/:_@;(>.(1S4^BI!TQ(,;
M\7CX0?AQ#VZ<>S\M-TA-#\*.C4=]+/&@'](+4G*H@X7D-#](R<)"\I"@6Q[Z
MB3H^A#Z6@LAC'F0_2$W3\4-V_R,<[A;/-62A"X)DPWZ@",4P"H(,51CC')#X
MAS\&00E+[,\@M7#%VS9QB5!T_[P@X,C$.O(1"DI(PAM(AP3&;T$)2H#B'0=Y
M1B2N48NTAF+@_T!'*%*A#$E08A/(0 @L%(&/0U""$[%X>#T\,0U?+.(2E<#'
MH=SPBV:T0R%KH(0N_/'V@V0B#+>@QQL=P0=2X,/L"%E'-PPQBU-DPA.O0'HQ
M *&*9$#"$Z48X#_. 0I..",5EZ"$\@P2#F!LPA>ZP,0B> LV" (E; $?W$$W
M',0YP,(GV$$2[,$GJ-P_; ,B7,(3Y,$=$ -"/(,J7 (1G($8=)=!$ ,F6 (G
M< (@E(+*A4,B4,(E<,(G%(* H,,L7,(+!H(@&,-!0,,F;$+O*4(K-)]![,,Y
MR%<]^/^#/VC7.9!#K_D#.U2=2S2A/W1'0:3#.;C7$?H#_(&#([2!)>@"RV2"
MPJV#+-R!)7C;/V "O?W#/:C!)3S"-_S#,'3"0=2#)F!"(YS".O0#)R#$,DR"
M-8P")G!"_EE>*,A",7"")WR7033#)"0#+WC")5#507##),2"*$3"(KB-0:Q#
M)2@"(U1"&IQ!(2B<-DA"(GQB$AR"#AK$/' "(7SB$F#"*QS$*!@"(E1"&!1!
M)VS</VS"/9@#*KC@*BC<-C3" G7")1B" AF$/V#"/] #(U#"(01>S6%>.VS>
M)GQ#UNE'/HC!/TC"TOQ#)#3C/PA"+,A#)A0$-GB"_O'!/W3_ E#]PR7PCD'
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M).(!T<A@G(\Z)$"!L#DA$!)A3N5!#/[ %XRA&4WB'/(2'/Y >2*!8P.ZPN(
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1Y<R;.W\./;KTZ=2K]PT( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_012.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_012.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M$/_KMKD&XJ0?$+  NQ85 #)-X$E.7$L%(."ASPWQBG:+(4T 4(%*T*4 %0#
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MQX]<!]!UCFD"ZLJ![&B@!4F>+G@F@6D#4$ "&?P.ATO"US$/F<AEC31)*8
M#FA "JX%JZ:]P]W=3A?2VGG>>$E2 2C$X==^B(,?^'#E"T!0U25];'0-H($D
MNY82 \ U #*@"9O.&CS8BXD]RA2/?$S@GR"I+;+7F8"I^O0$S@9ME[>CC@C0
MP]D<@"]X5,R2"J3CU'&J:':<YN)]H^9ICQYW3,O0VH(?]];<X<,]FFW3!W!
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MMZ->JGJ@!1'?CGQE@DGL#R0!4U0!&! F$)!V[?!QC=(H9<(F:A(!YD=GZ:=
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M W4X 3TW9ZT(C>PC!8'8BX7SCNL%5E77BC]84U(  $E& >?Q9#)1 OQ  !]
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MJK+KT5V%I0X^ZZCZ2A( $)CVL+"K@@$'45'6!U .A1K7)Q!\H!8BU:-0JS8
MNI1_FAWMUI]H)B"$Z5[L8;0G,0&)T A0$&Q2*#T? $C?QD7?5D7\1$\0T"19
M);=S^S52555]=X0M4&VN5B"LIJ3*^JH?,1WM4 &B40$D%R539"J;8B9N$JOE
M(B@FDU@30!U:6KETLS52H XM<&$%JAWT<&#ZT%L$D@#"1Z_J,:XM,1JATF]*
M]"GD9"9]%+N4A ]ZI$]R4(5D.[;J, G0Q+W>_QNV"QN^X/N]XVN^W8N^Y'N^
MXIN^[;N^[EN^[ZN^]#N_]BN_^,N^^1N_^MN__/N_\!O ];N_ GR__EO !#S
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M!U^KJ&20%77WA]<2DIZME5SH9%[I>5P4P $Q>B4\66^(!VSH:AW/R-BPIG<
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M"3P/ ,]#FPL/T+P C.UM#%#- 76X0Y7Q(0,ZFM%W-+&5CMQF$BD3C#JDL!L
MS.<@&O@A!_1'D?-LA0(9@%Q))D&!!Z2GB1G0Q&<$F"[.\5 B0#O.@427.M,]
M1 (4# H Y,:'00!%#L-#6\(6 P0&%& G<="C3"I0 CG8\  M1-L%-O0\L2T
M,<8C7E$>,@!U\($O3J(D)2TI1P!DLI*7[*0Z- E*3VX2DZ+\)"=+24I4FC*4
MHU1E*UD)RU/2\I6IK"4N;^G*5<;2EKW,)2]EZ4M= G.7LRSF,(.)3&':DB_K
M."8 -* WA%#_H!_V:($^>$80QTQ".)T$P#?M\9!QEA, YD3G.=6YSF_R11TQ
M(Q^2^' "#M!O(>)KP3-#Z4IHKN,\M3G902C Q0?T(P$#"*<WU9G.=#K)H9Q\
M:$0A.E&)5I2BG)2(.MIQ/"N@ 0U.JN0Z+,D'D?*%#W! #AS0 (,=. FC "!
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MV8$%B&  \/E9(@V:J^R5)4879A'IF#, $KCBPO@ @AC9,1PGG9@60F "$S@
MAF@\[0Q2YM/?[ISB/("  IZ@(!G EH?U)V-Z3 )1G!K0=W;-$=-<1<P<L8UP
M$A  JE! />\35$+_X,TQ6+GX7BH-](&*1@"4OH.-$&EX<MX!!T.3Y*C,(0 $
M+L"F&C+@ A>8P&.LK2L(;'M9/3%8B/!XW@5($MPO]]B2WA4!!Y/, /'YID1
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M:*E:F[40F!@$K.&VC 7<EY.^04D7G=,PBW21==B&KON+=B!%ZZ)3HEE"=DT
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M);91Q9)[D0<G'IR %4"C.$R+>&7_N'!653U7_>0#*[#3/L5GL&R'-K8,=9"
M01B$16X*.7@"=F"'!FB B+59 * :0+  U>C'_PTYXVD> +B  0BYC-N0D*N
MN)D ;-:CR2A3==ZA3SF9_["F '!&CK@\!PN<B> ,SO.!XY"X0',QDV16T+."
M=A@ :F8!0KB( #CHPC#1.@#C?>G$_9" 5F'92;!B %A7@K4MM=X&%,N2U+DR
MF>4@^50 .2V,?O!HP1@$%D#I!C !1GCF V0$$U#I0'@#EI;8,R90G@@D02(
M)*LI1'JA10H =1@;Q+"A#,(AH^:ALLA!;&P8%+K!>BB@Z[6*N%:*R&0V$CX0
M^9.'0SLC_Q4Q 1)@!Q)X LOTO]7#%]U;3)2"6BM(ND4;&N0EWH>&B)-*,<ID
MQ2L\#JA-48_F5(]"*1=8 -EVBB<@ <16:1,@Z:0H[ 9@!\-^ >5NWA8Z@'C
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M;0P4\3DZ*=J?']6 @*( *7!3I#!I%MB ,6 '1P\!. B!#3"!;K"";O!MQVZ
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M@"/A"P=,24:64@*X8DA1U$/E!<%M2%$]P1/4%2$0#SQUQ@;LP"*5UB3L37,
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M"X3,@>S -SS"2_!!6@!(+_G4.\!!"!Q%", %%=7(ABBC#RR".0Q&5F'96#E
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MBWED'!O_F^A&,II1B7T4Y!T3:<@R[I&.6ORC(ZO(14KJ$8^5A*,G#WE),D[
MCIKL)"<C"4K&Q7&4I:QD(;6XR3X^496/-&4J40G+07YRETOTXBQ=24@U'G**
M)3A W'S8%@M,@@"9X\L$ %"!"1PQ=G53BQSDDC>X:/,XW'R+-]L"3N( ( )R
ML29<SOE-<:KE(7%9YUK>>24^8=.=\\QF-MOYS7R^)9UN<9P[WTF/<FYS+O'<
MIUL.&LZ"FO.>]61H7 8*EXA^<Z')=(L$(#"!200@.!B%9@ J8#@)U T !X
M-T<ZNX_VY7&&"Y;>%.<6,D$  OVLP"!*6M.VT&," 5A 1L/9_].0]I0M$B #
M/2]ZU+B0H1U+;6I<FGE$"-@C6#4-*579$@$E8K2'657B.B#0U;[0U*168DM(
M(6!2FY)5IVS!7%J!6E6XM@ZF<VT+6DV*3'BR=0(3I1;F#L"7N54U9!SE9C/_
M@S>OGO1*=-4J4UU:5:EB=2U1#:DWM9H/C+(-, ^I #G;,BQZ" ^</!F$8K,Z
M+) "( $L!>D!Z,I1F,8VI26-!TI)FM%X6C0N2@P  RKPTW,"%;@A50=;/A"
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MLJKU&H T6_C_+*^&;@\Z')P.L\4"!P@ $-3"@!FO-QZ5* $V&6!6M20WK '
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M]$,C]%ORAD1!ZD+;+D7-CT%;="]>% +:2>^P;"V<,P#RX4*OKT!=])ST,T4
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G5<"5TUY_#7;88H]-=MEFGXUVVFJOS7;;;K\-=]QRSTUWW4T'!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>9
<FILENAME>dp235946_exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-16</xbrli:startDate>
          <xbrli:endDate>2025-10-16</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-16</xbrli:startDate>
          <xbrli:endDate>2025-10-16</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-16</xbrli:startDate>
          <xbrli:endDate>2025-10-16</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">4,260,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">10</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">42,600,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">5,883.06</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">42,600,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">5,883.06</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">5,883.06</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">42,600,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 16, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Oct. 16, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">4,260,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 42,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 5,883.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 16, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 42,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">5,883.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">5,883.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 42,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp235946_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp235946_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp235946_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp235946_exfilingfees.htm">dp235946_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp235946_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp235946_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235946_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235946_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235946_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235946_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235946_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp235946_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0000950103-25-013257-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-013257-xbrl.zip
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C:6QI;F=F965S+FAT;5!+!08      0 ! $<   "-"P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>dp235946_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-16</startDate>
            <endDate>2025-10-16</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-16</startDate>
            <endDate>2025-10-16</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-10-16</startDate>
            <endDate>2025-10-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">4260000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">10</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">42600000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">5883.06</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">42600000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">5883.06</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">5883.06</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">42600000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
